US20050214807A1 - Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection - Google Patents

Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection Download PDF

Info

Publication number
US20050214807A1
US20050214807A1 US10/993,908 US99390804A US2005214807A1 US 20050214807 A1 US20050214807 A1 US 20050214807A1 US 99390804 A US99390804 A US 99390804A US 2005214807 A1 US2005214807 A1 US 2005214807A1
Authority
US
United States
Prior art keywords
substituted
unsubstituted
heteroalkyl
alkyl
solid support
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/993,908
Other languages
English (en)
Inventor
Iain Johnson
Wai-Yee Leung
Jixiang Liu
Brian Patch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/993,908 priority Critical patent/US20050214807A1/en
Publication of US20050214807A1 publication Critical patent/US20050214807A1/en
Priority to US12/040,850 priority patent/US8173698B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B19/00—Oxazine dyes
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B1/00—Dyes with anthracene nucleus not condensed with any other ring
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B11/00—Diaryl- or thriarylmethane dyes
    • C09B11/04—Diaryl- or thriarylmethane dyes derived from triarylmethanes, i.e. central C-atom is substituted by amino, cyano, alkyl
    • C09B11/06—Hydroxy derivatives of triarylmethanes in which at least one OH group is bound to an aryl nucleus and their ethers or esters
    • C09B11/08—Phthaleins; Phenolphthaleins; Fluorescein
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B11/00—Diaryl- or thriarylmethane dyes
    • C09B11/04—Diaryl- or thriarylmethane dyes derived from triarylmethanes, i.e. central C-atom is substituted by amino, cyano, alkyl
    • C09B11/10—Amino derivatives of triarylmethanes
    • C09B11/24—Phthaleins containing amino groups ; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00—Other synthetic dyes of known constitution
    • C09B57/02—Coumarine dyes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing

Definitions

  • the present invention relates to fluorogenic reagents that are environmentally sensitive.
  • the invention has applications in the fields of immunology, diagnostics, molecular biology and fluorescence based assays.
  • probes that localize within cellular compartments e.g., cytosol, mitochondria, etc., particularly those implicated in the formation or reaction of singlet oxygen, would allow researchers to probe singlet oxygen formation and distribution at the subcellular level.
  • the present invention provides such fluorogenic probes, conjugates including the probes and methods of using both the probes and the conjugates.
  • Oxidatively sensitive fluorogenic probes such as those provided by the present invention, offer a number of advantages that are not realized with non-fluorescent probes for singlet oxygen.
  • fluorescent probes provide more sensitive measurement of singlet oxygen, the ability to take measurements in live cells over real time and the ability to combine the fluorogenic probes with other fluorogenic or fluorescent probes, in order to simultaneously investigate multiple parameters of live cellular function.
  • the present invention provides a novel class of anthracene-based fluorogenic probes that detect the presence of singlet oxygen.
  • anthracene moiety undergoes oxidative conversion by singlet oxygen to the corresponding anthracene-endoperoxide, e.g., anthracene-9,10-endoperoxide
  • the fluorogenic probe is converted into a fluorescent probe.
  • selected probes of the invention fluoresce without UV excitation, thereby allowing the detection of singlet oxygen while minimizing interfering signals from cell autofluorescence.
  • the probes of the invention also allow the collection of a wide variety of data, including data other than that directly available from interrogating the oxidized probe.
  • data other than that directly available from interrogating the oxidized probe For example, using probes of the current invention, mitochondria can be stained, the cell fixed and permeabilized, and a variety of labeling agents can then be utilized for simultaneous visualization of mitochondria and other cellular components.
  • the oxidized probes emit fluorescence over a comparatively narrow wavelength range, the probes are highly useful in multi-color/multi-parametric applications, including microscopy and flow cytometry.
  • the invention provides a fluorogenic probe that includes an oxidizable group such as an anthracene moiety bonded to a dye moiety.
  • the dye is fluorescein
  • the anthracene moiety is covalently bonded to the fluorescein dye moiety at the 9-position of the anthracene moiety.
  • the anthracene is substituted with at least one substituted or unsubstituted C 1 -C 6 alkyl moiety.
  • dye moieties are of use in the compounds of the invention.
  • exemplary dyes include substituted or unsubstituted coumarin, substituted or unsubstituted borapolyazaindacene (BODIPY), substituted or unsubstituted cyanine, substituted or unsubstituted styryl, substituted or unsubstituted dapoxyl, substituted or unsubstituted fluorescein, substituted or unsubstituted rhodamine, substituted or unsubstituted rhodol, substituted or unsubstituted oxazine, substituted or unsubstituted acridinone, and substituted or unsubstituted napthofluorescein.
  • the dye moieties of use in the compounds of the invention are those that provide a fluorophore excitable by visible light when the attached anthracene moiety is oxidized.
  • the fluorogenic probes and their oxidized fluorescent counterparts are used as free, unconjugated species or, optionally, they are conjugated to a reactive group, a carrier molecule, a solid support, or a combination thereof.
  • the invention provides methods in which the fluorogenic probes are used to detect and/or quantify singlet oxygen in a sample by detecting fluorescence in the sample.
  • the change in sample fluorescence is optionally detected in real time in certain applications.
  • the kinetics of singlet oxygen generation can be studied by following the time-course of the increase in sample fluorescence.
  • kits that include one or more fluorogenic or fluorescent probe of the invention and instructions for use of the probe.
  • FIG. 1 is a graphical presentation of data comparing the fluorescence of 1 ⁇ M of 5 ( ⁇ ) or 6 ( ⁇ ) in 100 mM 0.1 M phosphate buffer pH 10 as a function of time. Sodium molybdate (1 mM) and hydrogen peroxide (20 mM) were used as the singlet oxygen generation system.
  • FIG. 2 is a graphical presentation of data displaying fluorescence versus time traces for 1 ⁇ M of 5 in 50 mM phosphate buffer pH 7.5. Black bars above the x-axis indicate 30-second periods of 630-680 nm laser irradiation. Methylene blue (10 ⁇ M), ground state oxygen, and visible light were used as the singlet oxygen generation system.
  • FIG. 3 is a graphical comparison of the fluorescence intensity and wavelength fluorescence emission spectra for 5 in DMSO, methanol and aqueous solutions.
  • FIG. 3B is a graphical comparison of the fluorescence intensity and wavelength fluorescence emission spectra for 5 in DMSO, methanol and aqueous solutions.
  • FIG. 3B represents an approximately 10-fold enlargement of the y-axis over FIG. 3A .
  • FIG. 4 is a graphical presentation of data displaying fluorescence enhancement of 5 upon binding to BSA (0-5 ⁇ M) in PBS.
  • the inset graph shows the fluorescence intensity at the emission peak (540 nm) plotted against BSA concentration.
  • FIG. 5A is a graphical representation of data displaying fluorescence emission for 5 in DMSO with fractional additions of H 2 O. Intermediate H 2 O additions are 0.1, 0.2, 0.3, 0.4, 0.5, 1.0, 1.5, 2.0, 4.0, 6.0, 8.0% (v/v), reading from top to bottom.
  • FIG. 5B is a graphical representation of data displaying peak fluorescence intensities from FIG. 5A versus percentage (v/v) of water added to DMSO.
  • Fluorescent labels have the advantage of requiring few precautions in handling, and being amenable to high-throughput visualization techniques (optical analysis including digitization of the image for analysis in an integrated system comprising a computer).
  • Preferred labels are typically characterized by one or more of the following: high sensitivity, high stability, low background, low environmental sensitivity and high specificity in labeling.
  • the present invention provides a new class of compounds containing an anthracene moiety and a dye moiety that are of use in the detection of singlet oxygen in a variety of analytical and diagnostic techniques.
  • the present compounds demonstrate key advantages over known fluorogenic singlet oxygen sensors wherein they are stable over long periods of time (U.S. Pat. No. 5,525,088). This was an unexpected advantage that allows the present compounds to be marketed as commercial products.
  • Certain compounds of the present invention can exist in unsolvated forms as well as solvated forms, including hydrated forms. In general, the solvated forms are equivalent to unsolvated forms and are encompassed within the scope of the present invention. Certain compounds of the present invention may exist in multiple crystalline or amorphous forms. In general, all physical forms are equivalent for the uses contemplated by the present invention and are intended to be within the scope of the present invention.
  • Certain compounds of the present invention possess asymmetric carbon atoms (optical centers) or double bonds; the racemates, diastereomers, geometric isomers and individual isomers are encompassed within the scope of the present invention.
  • the compounds of the invention may be prepared as a single isomer (e.g., enantiomer, cis-trans, positional, diastereomer) or as a mixture of isomers.
  • the compounds are prepared as substantially a single isomer.
  • Methods of preparing substantially isomerically pure compounds are known in the art. For example, enantiomerically enriched mixtures and pure enantiomeric compounds can be prepared by using synthetic intermediates that are enantiomerically pure in combination with reactions that either leave the stereochemistry at a chiral center unchanged or result in its complete inversion. Alternatively, the final product or intermediates along the synthetic route can be resolved into a single stereoisomer.
  • the compounds of the present invention may also contain unnatural proportions of atomic isotopes at one or more of the atoms that constitute such compounds.
  • the compounds may be radiolabeled with radioactive isotopes, such as for example tritium ( 3 H), iodine-125 ( 125 I) or carbon-14 ( 14 C). All isotopic variations of the compounds of the present invention, whether radioactive or not, are intended to be encompassed within the scope of the present invention.
  • substituent groups are specified by their conventional chemical formulae, written from left to right, they equally encompass the chemically identical substituents, which would result from writing the structure from right to left, e.g., —CH 2 O— is intended to also recite —OCH 2 —.
  • acyl or “alkanoyl” by itself or in combination with another term, means, unless otherwise stated, a stable straight or branched chain, or cyclic hydrocarbon radical, or combinations thereof, consisting of the stated number of carbon atoms and an acyl radical on at least one terminus of the alkane radical.
  • the “acyl radical” is the group derived from a carboxylic acid by removing the —OH moiety therefrom.
  • alkyl by itself or as part of another substituent means, unless otherwise stated, a straight or branched chain, or cyclic hydrocarbon radical, or combination thereof, which may be fully saturated, mono- or polyunsaturated and can include divalent (“alkylene”) and multivalent radicals, having the number of carbon atoms designated (i.e. C 1 -C 10 means one to ten carbons).
  • saturated hydrocarbon radicals include, but are not limited to, groups such as methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, isobutyl, sec-butyl, cyclohexyl, (cyclohexyl)methyl, cyclopropylmethyl, homologs and isomers of, for example, n-pentyl, n-hexyl, n-heptyl, n-octyl, and the like.
  • An unsaturated alkyl group is one having one or more double bonds or triple bonds.
  • alkyl groups examples include, but are not limited to, vinyl, 2-propenyl, crotyl, 2-isopentenyl, 2-(butadienyl), 2,4-pentadienyl, 3-(1,4-pentadienyl), ethynyl, 1- and 3-propynyl, 3-butynyl, and the higher homologs and isomers.
  • alkyl unless otherwise noted, is also meant to include those derivatives of alkyl defined in more detail below, such as “heteroalkyl.” Alkyl groups that are limited to hydrocarbon groups are termed “homoalkyl”.
  • alkyl groups of use in the present invention contain between about one and about twenty five carbon atoms (e.g. methyl, ethyl and the like). Straight, branched or cyclic hydrocarbon chains having eight or fewer carbon atoms will also be referred to herein as “lower alkyl”.
  • alkyl as used herein further includes one or more substitutions at one or more carbon atoms of the hydrocarbon chain fragment.
  • alkoxy alkylamino and “alkylthio” (or thioalkoxy) are used in their conventional sense, and refer to those alkyl groups attached to the remainder of the molecule via an oxygen atom, an amino group, or a sulfur atom, respectively.
  • heteroalkyl by itself or in combination with another term, means, unless otherwise stated, a straight or branched chain, or cyclic carbon-containing radical, or combinations thereof, consisting of the stated number of carbon atoms and at least one heteroatom selected from the group consisting of O, N, Si, P and S, and wherein the nitrogen, phosphorous and sulfur atoms are optionally oxidized, and the nitrogen heteroatom is optionally quaternized.
  • the heteroatom(s) O, N, P, S and Si may be placed at any interior position of the heteroalkyl group or at the position at which the alkyl group is attached to the remainder of the molecule.
  • Examples include, but are not limited to, —CH 2 —CH 2 —O—CH 3 , —CH 2 —CH 2 —NH—CH 3 , —CH 2 —CH 2 —N(CH 3 )—CH 3 , —CH 2 —S—CH 2 —CH 3 , —CH 2 —CH 2 , —S(O)—CH 3 , —CH 2 —CH 2 —S(O) 2 —CH 3 , —CH ⁇ CH—O—CH 3 , —Si(CH 3 ) 3 , —CH 2 —CH ⁇ N—OCH 3 , and —CH ⁇ CH—N(CH 3 )—CH 3 .
  • heteroalkylene by itself or as part of another substituent means a divalent radical derived from heteroalkyl, as exemplified, but not limited by, —CH 2 —CH 2 —S—CH 2 —CH 2 — and —CH 2 —S—CH 2 —CH 2 —NH—CH 2 —.
  • heteroatoms can also occupy either or both of the chain termini (e.g., alkyleneoxy, alkylenedioxy, alkyleneamino, alkylenediamino, and the like). Still further, for alkylene and heteroalkylene linking groups, no orientation of the linking group is implied by the direction in which the formula of the linking group is written. For example, the formula —C(O) 2 R′— represents both —C(O) 2 R′— and —R′C(O) 2 —.
  • cycloalkyl and “heterocycloalkyl”, by themselves or in combination with other terms, represent, unless otherwise stated, cyclic versions of “alkyl” and “heteroalkyl”, respectively. Additionally, for heterocycloalkyl, a heteroatom can occupy the position at which the heterocycle is attached to the remainder of the molecule. Examples of cycloalkyl include, but are not limited to, cyclopentyl, cyclohexyl, 1-cyclohexenyl, 3-cyclohexenyl, cycloheptyl, and the like.
  • heterocycloalkyl examples include, but are not limited to, 1-(1,2,5,6-tetrahydropyridyl), 1-piperidinyl, 2-piperidinyl, 3-piperidinyl, 4-morpholinyl, 3-morpholinyl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydrothien-2-yl, tetrahydrothien-3-yl, 1-piperazinyl, 2-piperazinyl, and the like.
  • aryl means, unless otherwise stated, a polyunsaturated, aromatic moiety that can be a single ring or multiple rings (preferably from 1 to 3 rings), which are fused together or linked covalently.
  • heteroaryl refers to aryl groups (or rings) that contain from one to four heteroatoms selected from N, O, and S, wherein the nitrogen and sulfur atoms are optionally oxidized, and the nitrogen atom(s) are optionally quaternized.
  • a heteroaryl group can be attached to the remainder of the molecule through a heteroatom.
  • Non-limiting examples of aryl and heteroaryl groups include phenyl, 1-naphthyl, 2-naphthyl, 4-biphenyl, 1-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl, 3-pyrazolyl, 2-imidazolyl, 4-imidazolyl, pyrazinyl, 2-oxazolyl, 4-oxazolyl, 2-phenyl-4-oxazolyl, 5-oxazolyl, 3-isoxazolyl, 4-isoxazolyl, 5-isoxazolyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidyl, 4-pyrimidyl, 5-benzothiazolyl, purinyl, 2-benzimidazolyl, 5-indolyl, 1-isoquinoly
  • aryl when used in combination with other terms (e.g., aryloxy, arylthioxy, arylalkyl) includes both aryl and heteroaryl rings as defined above.
  • arylalkyl is meant to include those radicals in which an aryl group is attached to an alkyl group (e.g., benzyl, phenethyl, pyridylmethyl and the like) including those alkyl groups in which a carbon atom (e.g., a methylene group) has been replaced by, for example, an oxygen atom (e.g., phenoxymethyl, 2-pyridyloxymethyl, 3-(1-naphthyloxy)propyl, and the like).
  • alkyl group e.g., benzyl, phenethyl, pyridylmethyl and the like
  • an oxygen atom e.g., phenoxymethyl, 2-pyridyloxymethyl, 3-(1-naph
  • alkyl and heteroalkyl radicals are generically referred to as “alkyl group substituents,” and they can be one or more of a variety of groups selected from, but not limited to: —OR′, ⁇ O, ⁇ NR′, ⁇ N—OR′, —NR′R′′, —SR′, -halogen, —SiR′R′′ R′′′, —OC(O)R′, —C(O)R′, —CO 2 R′, —CONR′R′′, —OC(O)NR′R′′, —NR′′C(O)R′, —NR′—C(O)NR′′R′′′, —NR′′C(O) 2 R′, ——OR′, ⁇ O, ⁇ NR′, ⁇ N—OR′, —NR′R′′, —SR′, -halogen, —SiR′R′′ R′′′, —OC(O)R′, —C(O)R′, —CO 2 R′
  • R′, R′′, R′′′ and R′′′′ each preferably independently refer to hydrogen, substituted or unsubstituted heteroalkyl, substituted or unsubstituted aryl, e.g., aryl substituted with 1-3 halogens, substituted or unsubstituted alkyl, alkoxy or thioalkoxy groups, or arylalkyl groups.
  • each of the R groups is independently selected as are each R′, R′′, R′′′ and R′′′′ groups when more than one of these groups is present.
  • R′ and R′′ are attached to the same nitrogen atom, they can be combined with the nitrogen atom to form a 5-, 6-, or 7-membered ring.
  • —NR′R′′ is meant to include, but not be limited to, 1-pyrrolidinyl and 4-morpholinyl.
  • alkyl is meant to include groups including carbon atoms bound to groups other than hydrogen groups, such as haloalkyl (e.g., —CF 3 and —CH 2 CF 3 ) and acyl (e.g., —C(O)CH 3 , —C(O)CF 3 , —C(O)CH 2 OCH 3 , and the like).
  • haloalkyl e.g., —CF 3 and —CH 2 CF 3
  • acyl e.g., —C(O)CH 3 , —C(O)CF 3 , —C(O)CH 2 OCH 3 , and the like.
  • substituents for the aryl and heteroaryl groups are generically referred to as “aryl group substituents.”
  • the substituents are selected from, for example: halogen, —OR′, ⁇ O, ⁇ NR′, ⁇ N—OR′, —NR′R′′, —SR′, -halogen, —SiR′R′′ R′′′, —OC(O)R′, —C(O)R′, —CO 2 R′, —CONR′R′′, —OC(O)NR′R′′, —NR′′C(O)R′, —NR′—C(O)NR′′R′′′, —NR′′C(O) 2 R′, —NR—C(NR′R′′ R′′′) ⁇ NR′′′′, —NR—C(NR′R′′) ⁇ NR′′′, —S(O)R′, —S(O) 2 R′, —S(O) 2 NR′R′′
  • each of the R groups is independently selected as are each R′, R′′, R′′′ and R′′′′ groups when more than one of these groups is present.
  • the symbol X represents “R” as described above.
  • Two of the substituents on adjacent atoms of the aryl or heteroaryl ring may optionally be replaced with a substituent of the formula -T-C(O)—(CRR′) q —U—, wherein T and U are independently —NR—, —O—, —CRR′— or a single bond, and q is an integer of from 0 to 3.
  • two of the substituents on adjacent atoms of the aryl or heteroaryl ring may optionally be replaced with a substituent of the formula -A-(CH 2 ) r —B—, wherein A and B are independently —CRR′—, —O—, —NR—, —S—, —S(O)—, —S(O) 2 —, —S(O) 2 NR′— or a single bond, and r is an integer of from 1 to 4.
  • One of the single bonds of the new ring so formed may optionally be replaced with a double bond.
  • two of the substituents on adjacent atoms of the aryl or heteroaryl ring may optionally be replaced with a substituent of the formula —(CRR′) s —X—(CR′′R′′′) d —, where s and d are independently integers of from 0 to 3, and X is —O—, —NR′—, —S—, —S(O)—, —S(O) 2 —, or —S(O) 2 NR′—.
  • the substituents R, R′, R′′ and R′′′ are preferably independently selected from hydrogen or substituted or unsubstituted (C 1 -C 6 )alkyl.
  • heteroatom includes oxygen (O), nitrogen (N), sulfur (S), phosphorus (P) and silicon (Si).
  • amino refers to the group —NR′R′′ (or N + RR′R′′) where R, R′ and R′′ are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, aryl alkyl, substituted aryl alkyl, heteroaryl, and substituted heteroaryl.
  • a substituted amine being an amine group wherein R′ or R′′ is other than hydrogen. In a primary amino group, both R′ and R′′ are hydrogen, whereas in a secondary amino group, either, but not both, R′ or R′′ is hydrogen.
  • the terms “amine” and “amino” can include protonated and quaternized versions of nitrogen, comprising the group —N + RR′R′′ and its biologically compatible anionic counterions.
  • aqueous solution refers to a solution that is predominantly water and retains the solution characteristics of water. Where the aqueous solution contains solvents in addition to water, water is typically the predominant solvent.
  • buffer refers to a system that acts to minimize the change in acidity or basicity of the solution against addition or depletion of chemical substances.
  • carbonyl refers to the functional group —(C ⁇ O)—. However, it will be appreciated that this group may be replaced with other well-known groups that have similar electronic and/or steric character, such as thiocarbonyl (—(C ⁇ S)—); sulfinyl (—S(O)—); sulfonyl (—SO 2 )—), phosphonyl (—PO 2 —).
  • Carboxyalkyl refers to a group having the general formula —(CH 2 ) n COOH wherein n is 1-18.
  • carrier molecule refers to a fluorogenic, fluorescent or colorimetric compound of the present invention that is covalently bonded to a biological or a non-biological component.
  • Such components include, but are not limited to, an amino acid, a peptide, a protein, a polysaccharide, a nucleoside, a nucleotide, an oligonucleotide, a nucleic acid, a hapten, a psoralen, a drug, a hormone, a lipid, a lipid assembly, a synthetic polymer, a polymeric microparticle, a biological cell, a virus and combinations thereof.
  • detectable response refers to an occurrence of or a change in, a signal that is directly or indirectly detectable either by observation or by instrumentation.
  • the detectable response is an optical response resulting in a change in the wavelength distribution patterns or intensity of absorbance or fluorescence or a change in light scatter, fluorescence lifetime, fluorescence polarization, or a combination of the above parameters.
  • die refers to a compound that emits light to produce an observable detectable signal. “Dye” includes fluorescent and nonfluorescent compounds that include without limitations pigments, fluorophores, chemiluminescent compounds, luminescent compounds and chromophores.
  • fluorophore refers to a composition that is inherently fluorescent or demonstrates a change in fluorescence upon binding to a biological compound or metal ion, or metabolism by an enzyme, i.e., fluorogenic. Fluorophores may be substituted to alter the solubility, spectral properties or physical properties of the fluorophore. Fluorophores of the present invention are not sulfonated.
  • fluorophores are known to those skilled in the art and include, but are not limited to benzofurans, quinolines, quinazolinones, indoles, benzazoles, borapolyazaindacenes and xanthenes, with the latter including fluoresceins, rhodamines and rhodols as well as other fluorophores described in RICHARD P. HAUGLAND, MOLECULAR PROBES HANDBOOK OF FLUORESCENT PROBES AND RESEARCH CHEMICALS (9 th edition, including the CD-ROM, September 2002).
  • kit refers to a packaged set of related components, typically one or more compounds or compositions.
  • Linker refers to a single covalent bond or a series of stable covalent bonds incorporating 1-20 nonhydrogen atoms selected from the group consisting of C, N, O, S and P that covalently attach the fluorogenic or fluorescent compounds to another moiety such as a chemically reactive group or a biological and non-biological component.
  • exemplary linking members include a moiety that includes —C(O)NH—, —C(O)O—, —NH—, —S—, —O—, and the like.
  • a “cleavable linker” is a linker that has one or more cleavable groups that may be broken by the result of a reaction or condition.
  • cleavable group refers to a moiety that allows for release of a portion, e.g., a fluorogenic or fluorescent moiety, of a conjugate from the remainder of the conjugate by cleaving a bond linking the released moiety to the remainder of the conjugate. Such cleavage is either chemical in nature, or enzymatically mediated.
  • exemplary enzymatically cleavable groups include natural amino acids or peptide sequences that end with a natural amino acid.
  • cleaved groups include, but are not limited to, acids, bases, light (e.g., nitrobenzyl derivatives, phenacyl groups, benzoin esters), and heat.
  • cleaveable groups are known in the art. See, for example, Jung et al., Biochem. Biophys. Acta, 761: 152-162 (1983); Joshi et al., J. Biol. Chem., 265: 14518-14525 (1990); Zarling et al., J.
  • An exemplary cleavable group, an ester is cleavable group that may be cleaved by a reagent, e.g. sodium hydroxide, resulting in a carboxylate-containing fragment and a hydroxyl-containing product.
  • a reagent e.g. sodium hydroxide
  • the linker can be used to attach the compound to another component of a conjugate, such as a targeting moiety (e.g., antibody, ligand, non-covalent protein-binding group, etc.), an analyte, a biomolecule, a drug and the like.
  • a targeting moiety e.g., antibody, ligand, non-covalent protein-binding group, etc.
  • an analyte e.g., an analyte, a biomolecule, a drug and the like.
  • protein and “polypeptide” are used herein in a generic sense to include polymers of amino acid residues of any length.
  • peptide refers to a polymer in which the monomers are amino acids and are joined together through amide bonds, alternatively referred to as a polypeptide.
  • the amino acids are ⁇ -amino acids
  • either the L -optical isomer or the D -optical isomer can be used.
  • unnatural amino acids for example, ⁇ -alanine, phenylglycine and homoarginine are also included. Commonly encountered amino acids that are not gene-encoded may also be used in the present invention.
  • All of the amino acids used in the present invention may be either the D - or L -isomer.
  • the L -isomers are generally preferred.
  • other peptidomimetics are also useful in the present invention.
  • Spatola, A. F. in Chemistry and Biochemistry of Amino Acids, Peptides and Proteins , B. Weinstein, eds., Marcel Dekker, New York, p. 267 (1983).
  • reactive group refers to a group that is capable of reacting with another chemical group to form a covalent bond, i.e. is covalently reactive under suitable reaction conditions, and generally represents a point of attachment for another substance.
  • the reactive group is a moiety, such as carboxylic acid or succinimidyl ester, on the compounds of the present invention that is capable of chemically reacting with a functional group on a different compound to form a covalent linkage.
  • Reactive groups generally include nucleophiles, electrophiles and photoactivatable groups.
  • Exemplary reactive groups include, but are not limited to, olefins, acetylenes, alcohols, phenols, ethers, oxides, halides, aldehydes, ketones, carboxylic acids, esters, amides, cyanates, isocyanates, thiocyanates, isothiocyanates, amines, hydrazines, hydrazones, hydrazides, diazo, diazonium, nitro, nitriles, mercaptans, sulfides, disulfides, sulfoxides, sulfones, sulfonic acids, sulfinic acids, acetals, ketals, anhydrides, sulfates, sulfenic acids isonitriles, amidines, imides, imidates, nitrones, hydroxylamines, oximes, hydroxamic acids thiohydroxamic acids, allenes, ortho esters, sulfites
  • Reactive functional groups also include those used to prepare bioconjugates, e.g., N-hydroxysuccinimide esters, maleimides and the like. Methods to prepare each of these functional groups are well known in the art and their application to or modification for a particular purpose is within the ability of one of skill in the art (see, for example, Sandler and Karo, eds. O RGANIC F UNCTIONAL G ROUP P REPARATIONS , Academic Press, San Diego, 1989).
  • salts of the agents of the invention includes salts of the agents of the invention and their conjugates, which are preferably prepared with relatively nontoxic acids or bases, depending on the particular substituents found on the compounds described herein.
  • base addition salts can be obtained by contacting the neutral form of such compounds with a sufficient amount of the desired base, either neat or in a suitable inert solvent.
  • base addition salts include sodium, potassium, calcium, ammonium, organic amino, or magnesium, or a similar salt.
  • acid addition salts can be obtained by contacting the neutral form of such compounds with a sufficient amount of the desired acid, either neat or in a suitable inert solvent.
  • addition salts include those derived from inorganic acids like hydrochloric, hydrobromic, nitric, carbonic, monohydrogencarbonic, phosphoric, monohydrogenphosphoric, dihydrogenphosphoric, sulfuric, monohydrogensulfuric, hydriodic, or phosphorous acids and the like, as well as the salts derived from relatively nontoxic organic acids like acetic, propionic, isobutyric, maleic, malonic, benzoic, succinic, suberic, fumaric, lactic, mandelic, phthalic, benzenesulfonic, p-tolylsulfonic, citric, tartaric, methanesulfonic, and the like.
  • salts of amino acids such as arginate and the like, and salts of organic acids like glucuronic or galactunoric acids and the like (see, for example, Berge et al., “Pharmaceutical Salts”, Journal of Pharmaceutical Science, 1977, 66,1-19).
  • Certain specific compounds of the present invention contain both basic and acidic functionalities that allow the compounds to be converted into either base or acid addition salts.
  • sample refers to any material that may contain singlet oxygen.
  • the sample may also include diluents, buffers, detergents, and contaminating species, debris and the like that are found mixed with the target.
  • Illustrative examples include urine, sera, blood plasma, total blood, saliva, tear fluid, cerebrospinal fluid, secretory fluids and the like.
  • solid, gel or solid substances such as mucus, body tissues, cells and the like suspended or dissolved in liquid materials such as buffers, extractants, solvents and the like.
  • the sample is a live cell, a biological fluid that comprises endogenous host cell proteins, nucleic acid polymers, nucleotides, oligonucleotides, peptides and buffer solutions.
  • the sample may be in an aqueous solution, a viable cell culture or immobilized on a solid or semi solid surface such as a polyacrylamide gel, membrane blot or on a microarray.
  • solid support refers to a material that is substantially insoluble in a selected solvent system, or which can be readily separated (e.g., by precipitation) from a selected solvent system in which it is soluble.
  • Solid supports useful in practicing the present invention can include groups that are activated or capable of activation to allow selected species to be bound to the solid support.
  • Solid supports may be present in a variety of forms, including a chip, wafer or well, onto which an individual, or more than one compound, of the invention is bound such as a polymeric bead or particle.
  • sulfoalkyl refers to a group having the general formula —(CH 2 ) n SO 3 wherein n is 1-18.
  • the dye moieties and oxidizable moieties will first be described in detail, followed by the many and varied methods in which the compounds find uses, which is followed by exemplified methods of use and synthesis of certain novel compounds that are particularly advantageous for use with the methods of the present invention.
  • the present invention provides fluorogenic compounds useful for the detection of singlet oxygen.
  • the compounds are generally represented by the general formula D-(L) n -M, wherein D is a dye moiety, L is a linker, M is an oxidizable moiety and n is 0 or 1.
  • the compounds include a dye moiety covalently bonded to an aryl or heteroaryl moiety, e.g. anthracene, wherein after being oxidized by singlet oxygen becomes fluorescent.
  • These fluorescent compounds have applications as dye compounds in any application wherein a fluorescent dye is useful.
  • the components of the compounds of the invention are disclosed in greater detail below.
  • Dye moieties include, without limitation, a chromophore, a fluorophore, a fluorescent protein, a phosphorescent dye, and a tandem dye (energy transfer pair).
  • Preferred dye moieties include chromophores or fluorophores.
  • a dye of the present invention is any chemical moiety that exhibits an absorption maximum beyond 280 nm.
  • Dyes of the present invention include, without limitation; a pyrene, an anthracene, a naphthalene, an acridine, a stilbene, an indole or benzindole, an oxazole or benzoxazole, a thiazole or benzothiazole, a 4-amino-7-nitrobenz-2-oxa-1,3-diazole (NBD), a carbocyanine (including any corresponding compounds in U.S. Ser. Nos. 09/557,275; 09/968,401 and 09/969,853 and U.S. Pat. Nos.
  • oxazines include resorufins (including any corresponding compounds disclosed in 5,242,805), aminooxazinones, diaminooxazines, and their benzo-substituted analogs.
  • the dye is a xanthene
  • the dye is optionally a fluorescein, a rhodol (including any corresponding compounds disclosed in U.S. Pat. Nos. 5,227,487 and 5,442,045), a rhodamine (including any corresponding compounds in U.S. Pat. Nos. 5,798,276 and 5,846,737).
  • rhodamine and rhodol dyes include, among other derivatives, compounds that comprise xanthenes with saturated or unsaturated “julolidine” rings.
  • fluorescein includes benzo- or dibenzofluoresceins, seminaphthofluoresceins, or naphthofluoresceins.
  • rhodol includes seminaphthorhodafluors (including any corresponding compounds disclosed in U.S. Pat. No. 4,945,171).
  • Preferred dyes of the present invention include xanthene, oxazine, dapoxyl, 7-nitro-1,2,3-benzoxadiazole (NBD), acridinone, carbocyanine compounds and borapolyazaindacenes.
  • Preferred xanthenes include fluoresceins, rhodols, rhodamines and rosamines.
  • Xanthenes of this invention comprise both compounds substituted and unsubstituted on the carbon atom of the central ring of the xanthene by substituents typically found in the xanthene-based dyes such as phenyl and substituted-phenyl moieties.
  • dyes are rhodamine, fluorescein, borapolyazaindacene, indole and benzofuran.
  • the choice of the dye will determine the fluorescent compound's absorption and fluorescence emission properties as well as its live cell properties, i.e. ability to enter live cells.
  • the dye contains one or more aryl or heteroaryl rings that are optionally substituted one or more times by a variety of substituents.
  • the substituents are selected from, for example: alkyl, perfluoroalkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, arylalkyl, acyl, aryl, heteroaryl, —OR′, ⁇ O, ⁇ NR′, ⁇ N—OR′, —NR′R′′, —SR′, -halogen, —SiR′R′′ R′′′, —OC(O)R′, —C(O)R′, —CO 2 R′, —CONR′R′′, —OC(O)NR′R′′, —NR′′C(O)R′, —NR′—C(O)NR′′R′′′, —NR′′C(O) 2 R′, —NR—C(NR′R′′ R′′′) ⁇ NR′′′′, —NR—
  • R′, R′′, R′′′ and R′′′′ preferably independently represent hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl.
  • each of the R groups is independently selected as are each R′, R′′, R′′′ and R′′′′ groups when more than one of these groups is present.
  • the symbol X represents “R” as described above.
  • the dye has an absorption maximum beyond 480 nm.
  • the dye absorbs at or near 488 nm to 514 nm (particularly suitable for excitation by the output of the argon-ion laser excitation source) or near 546 nm (particularly suitable for excitation by a mercury arc lamp).
  • they can also function as both chromophores and fluorophores, resulting in compounds that simultaneously act both as colorimetric and fluorescent probes for singlet oxygen.
  • the described fluorescent dyes are also the preferred chromophores of the present invention.
  • the dye moiety has a formula which is a member selected from:
  • At least one member selected from R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 is a substituted or unsubstituted anthracene moiety. If the index m represents 1 and R 8 is substituted or unsubstituted anthracene, then the anthracene moiety is not attached through the 3-position, and the anthracene moiety does not have a carboxylic acid moiety covalently bonded to its 2-position.
  • R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 are independently hydrogen, —OH, —NO 2 , —NR 12 R 13 , —SO 2 R 12 , halogen, substituted alkyl, unsubstituted alkyl, substituted heteroalkyl, unsubstituted heteroalkyl, substituted cycloalkyl, unsubstituted cycloalkyl, substituted heterocycloalkyl, unsubstituted heterocycloalkyl, substituted aryl, unsubstituted aryl, substituted heteroaryl, unsubstituted heteroaryl, substituted reactive group, unsubstituted reactive group, substituted carrier molecule, unsubstituted carrier molecule, substituted solid support, unsubstituted solid support, substituted anthracene moiety or a unsubstituted anthracene moiety.
  • R 6 in combination with R 7 ; R 7 in combination with R 10 ; R 10 in combination with R 2 ; R 3 in combination with R 11 ; R 11 in combination with R 4 ; or R 4 in combination with R 5 together with the atoms to which they are joined, form a ring which is a 5-, 6- or 7-membered cycloalkyl, a substituted 5-, 6- or 7-membered cycloalkyl, a 5-, 6- or 7-membered heterocycloalkyl, a substituted 5-, 6- or 7-membered heterocycloalkyl, a 5-, 6- or 7-membered aryl, a substituted 5-, 6- or 7-membered aryl, a 5-, 6- or 7-membered heteroaryl, or a substituted 5-, 6- or 7-membered heteroaryl.
  • R 12 and R 13 are independently hydrogen, —OH, —NH 2 , substituted alkyl, unsubstituted alkyl, substituted heteroalkyl, unsubstituted heteroalkyl, substituted cycloalkyl, unsubstituted cycloalkyl, substituted heterocycloalkyl, unsubstituted heterocycloalkyl, substituted aryl, unsubstituted aryl, substituted heteroaryl, or unsubstituted heteroaryl.
  • R 8 is hydrogen, halogen, cyano, substituted alkyl, unsubstituted alkyl, substituted heteroalkyl, unsubstituted heteroalkyl, substituted aryl, unsubstituted aryl (e.g. phenyl), substituted reactive group, unsubstituted reactive group, substituted carrier molecule, unsubstituted carrier molecule, substituted solid support, unsubstituted solid support.
  • R 8 is:
  • R 14 , R 15 , R 16 , R 17 and R 13 represent groups that are independently hydrogen, —OH, —NO 2 , —NR 12 R 13 , —SO 2 R 12 , CO 2 R 12 , halogen, substituted alkyl, unsubstituted alkyl, substituted heteroalkyl, unsubstituted heteroalkyl, substituted reactive group, unsubstituted reactive group, substituted carrier molecule, unsubstituted carrier molecule, substituted solid support, or unsubstituted solid support.
  • the symbol X represents C or N.
  • the index m is 0 and 1.
  • the index n is O and 1.
  • R 9 is hydrogen, —OH, halogen, —CN, —NO 2 , —NR 12 R 13 , —SO 2 R 12 , substituted alkyl, unsubstituted alkyl, substituted heteroalkyl, unsubstituted heteroalkyl, substituted reactive group, unsubstituted reactive group, substituted carrier molecule, unsubstituted carrier molecule, substituted solid support, or unsubstituted solid support.
  • a member selected from R 9 in combination with R 8 ; or R 9 in combination with R 14 together with the atoms to which they are joined form a substituted 5- or 6-membered spirolactone ring, unsubstituted 5- or 6-membered spirolactone ring, substituted 5- or 6-membered spirosultone ring or unsubstituted 5- or 6-membered spirosultone ring.
  • R 10 is —OR 30 or —NR 30 OR 12 .
  • R 11 is hydrogen, substituted alkyl, unsubstituted alkyl, substituted heteroalkyl, unsubstituted heteroalkyl, substituted acyl, unsubstituted acyl, substituted heteroacyl, unsubstituted heteroacyl, substituted cycloalkyl, unsubstituted cycloalkyl, substituted heterocycloalkyl, unsubstituted heterocycloalkyl, substituted aryl, unsubstituted aryl, substituted heteroaryl, or unsubstituted heteroaryl.
  • R 30 is a member selected from H, substituted or unsubstituted C 1 -C 18 alkyl, substituted or unsubstituted C 1 -C 18 heteroalkyl, substituted or unsubstituted C 1 -C 18 acyl, substituted or unsubstituted C 1 -C 18 heteroacyl, substituted or unsubstituted C 1 -C 18 aryl, and substituted or unsubstituted C 1 -C 18 heteroaryl.
  • a member selected from R 9 in combination with R 8 , or R 9 in combination with R 14 together with the atoms to which they are joined optionally form a substituted or unsubstituted 5- or 6-membered spirolactone or spirosultone ring.
  • R 30 in combination with R 2 ; or R 30 in combination with R 7 together with the atoms to which they are joined form a ring which is a 5-, 6- or 7-membered cycloalkyl, a substituted 5-, 6- or 7-membered cycloalkyl, a 5-, 6- or 7-membered heterocycloalkyl, a substituted 5-, 6- or 7-membered heterocycloalkyl, a 5-, 6- or 7-membered aryl, a substituted 5-, 6- or 7-membered aryl, a 5-, 6- or 7-membered heteroaryl, or a substituted 5-, 6- or 7-membered heteroaryl.
  • the compound has a structure according to the following formula: in which at least one member selected from R 32 , R 33 , R 34 , R 35 , R 36 , and R 37 is a substituted or unsubstituted anthracene moiety.
  • R 32 , R 33 , R 34 , R 35 , R 36 , and R 37 are independently selected from H, OH, —NO 2 , —NR 12 R 13 , —SO 2 R 12 , halogen, a reactive group, a carrier molecule, substituted or unsubstituted C 1 -C 18 alkyl, substituted or unsubstituted C 1 -C 18 heteroalkyl, substituted or unsubstituted C 1 -C 18 cycloalkyl, substituted or unsubstituted C 1 -C 18 heterocycloalkyl, substituted or unsubstituted C 1 -C 18 aryl, and substituted or unsubstituted C 1 -C 18 heteroaryl.
  • R 12 and R 13 are independently selected from H, substituted or unsubstituted C 1 -C 18 alkyl, substituted or unsubstituted C 1 -C 18 heteroalkyl, substituted or unsubstituted C 1 -C 18 cycloalkyl, substituted or unsubstituted C 1 -C 18 heterocycloalkyl, substituted or unsubstituted C 1 -C 18 aryl, and substituted or unsubstituted C 1 -C 18 heteroaryl.
  • the compound has a structure according to the following formula: in which at least one member selected from R 42 , R 43 , R 44 , R 45 , R 46 , R 47 and R 48 is a substituted or unsubstituted anthracene moiety.
  • R 42 , R 43 , R 44 , R 45 , R 46 , R 47 and R 48 are independently selected from H, —OH, —NO 2 , —NR 12 R 13 , —SO 2 R 12 , halogen, a reactive group, a carrier molecule, substituted or unsubstituted C 1 -C 18 alkyl, substituted or unsubstituted C 1 -C 18 heteroalkyl, substituted or unsubstituted C 1 -C 18 cycloalkyl, substituted or unsubstituted C 1 -C 18 heterocycloalkyl, substituted or unsubstituted C 1 -C 18 aryl, and substituted or unsubstituted C 1 -C 18 heteroaryl.
  • R 12 and R 13 are independently selected from H, —OH, —NH 2 , substituted or unsubstituted C 1 -C 18 alkyl, substituted or unsubstituted C 1 -C 18 heteroalkyl, substituted or unsubstituted C 1 -C 18 cycloalkyl, substituted or unsubstituted C 1 -C 18 heterocycloalkyl, substituted or unsubstituted C 1 -C 18 aryl, and substituted or unsubstituted C 1 -C 18 heteroaryl.
  • Oxidizable Moiety is independently selected from H, —OH, —NH 2 , substituted or unsubstituted C 1 -C 18 alkyl, substituted or unsubstituted C 1 -C 18 heteroalkyl, substituted or unsubstituted C 1 -C 18 cycloalkyl, substituted or unsubstituted C 1 -C 18 heterocycloalkyl, substituted
  • the compounds of the invention include an oxidizable aryl or heteroaryl moiety attached to the dye moiety.
  • An exemplary oxidizable moiety is a substituted or unsubstituted anthracene.
  • the bond between the dye moiety and the oxidizable moiety can be formed between atoms at any acceptable position on these two molecules.
  • the compounds of the invention are fluorogenic and therefore capable of a change in fluorescence upon the binding of singlet oxygen.
  • the oxidizable moiety is an anthracene, which has the following formula:
  • R 19 , R 20 , R 21 , R 22 , R 23 , R 24 , R 25 , R 26 and R 27 are independently hydrogen, halogen, SO 2 R 12 , CO 2 R 12 , substituted alkyl, unsubstituted alkyl, substituted heteroalkyl, unsubstituted heteroalkyl, substituted cycloalkyl, unsubstituted cycloalkyl, substituted heterocycloalkyl, unsubstituted heterocycloalkyl, substituted aryl, unsubstituted aryl, substituted heteroaryl, or unsubstituted heteroaryl, substituted reactive group, unsubstituted reactive group, substituted carrier molecule, unsubstituted carrier molecule, substituted solid support, or unsubstituted solid support.
  • R 12 is hydrogen, —OH, —NH 2 , substituted alkyl, unsubstituted alkyl, substituted heteroalkyl, unsubstituted heteroalkyl, substituted cycloalkyl, unsubstituted cycloalkyl, substituted heterocycloalkyl, unsubstituted heterocycloalkyl, substituted aryl, unsubstituted aryl, substituted heteroaryl, or unsubstituted heteroaryl.
  • the anthracene when the dye moiety is fluorescein, and the fluorescein is covalently bonded at its 9-position to the anthracene moiety at its 3-position, then the anthracene does not have a carboxylic acid substituted at its 2-position.
  • the compound has a formula which is a member selected from:
  • R 2 , R 3 , R 5 , and R 6 are H.
  • Representative compounds of the invention have a formula which is a member selected from:
  • the invention provides compounds having the formula:
  • R 32 , R 34 , and R 37 are H.
  • R 36 is —OH and R 33 is —CH 3 .
  • the compound is:
  • R 43 , R 44 , R 45 , and R 47 are H.
  • R 46 and R 48 are —CH 3 .
  • the compounds of the invention are fluorescent, due to the covalent bonding of singlet oxygen to the oxidizable moiety.
  • the oxidizable moiety has been oxidized and is anthracene endoperoxide, which has the following formula:
  • R 19 , R 20 , R 21 , R 22 , R 23 , R 24 , R 25 , R 26 and R 27 are independently selected from H, halogen, —SO 2 R 12 , substituted or unsubstituted C 1 -C 18 alkyl, substituted or unsubstituted C 1 -C 18 heteroalkyl, substituted or unsubstituted C 1 -C 18 cycloalkyl, substituted or unsubstituted C 1 -C 18 heterocycloalkyl, substituted or unsubstituted C 1 -C 18 aryl, substituted or unsubstituted C 1 -C 18 heteroaryl, a reactive group, and a carrier molecule.
  • R 12 represents H, —OH, —NH 2 , substituted or unsubstituted C 1 -C 18 alkyl, substituted or unsubstituted C 1 -C 18 heteroalkyl, substituted or unsubstituted C 1 -C 18 cycloalkyl, substituted or unsubstituted C 1 -C 18 heterocycloalkyl, substituted or unsubstituted C 1 -C 18 aryl, and substituted or unsubstituted C 1 -C 18 heteroaryl.
  • the compound has a formula which is a member selected from: in which the substituents are identical to those described in the generic formulae for the corresponding unoxidized compounds.
  • R 2 , R 3 , R 5 , and R 6 are H.
  • the compound has a formula which is a member selected from:
  • the compound is:
  • R 32 , R 34 , and R 37 are H.
  • R 36 is —OH and R 33 is —CH 3 .
  • the compound is:
  • R 43 , R 44 , R 45 , and R 47 are H.
  • R 46 and R 48 are —CH 3 .
  • the present compounds are chemically reactive wherein the compounds comprise a reactive group.
  • the compounds comprise a carrier molecule or solid support.
  • These substituents, reactive groups, carrier molecules, and solid supports comprise a linker that is used to covalently attach the substituents to any of the moieties of the present compounds.
  • the solid support, carrier molecule or reactive group may be directly attached (where linker is a single bond) to the moieties or attached through a series of stable bonds.
  • linkers may be used to attach the carrier molecule, solid support or reactive group and the present compounds together.
  • the linker may also be substituted to alter the physical properties of the fluorogenic compound, such as spectral properties of the dye.
  • the linker typically incorporates 1-30 nonhydrogen atoms selected from the group consisting of C, N, O, S and P.
  • the linker may be any combination of stable chemical bonds, optionally including, single, double, triple or aromatic carbon-carbon bonds, as well as carbon-nitrogen bonds, nitrogen-nitrogen bonds, carbon-oxygen bonds, sulfur-sulfur bonds, carbon-sulfur bonds, phosphorus-oxygen bonds, phosphorus-nitrogen bonds, and nitrogen-platinum bonds.
  • the linker incorporates less than 15 nonhydrogen atoms and are composed of any combination of ether, thioether, thiourea, amine, ester, carboxamide, sulfonamide, hydrazide bonds and aromatic or heteroaromatic bonds.
  • the linker is a combination of single carbon-carbon bonds and carboxamide, sulfonamide or thioether bonds.
  • the bonds of the linker typically result in the following moieties that can be found in the linker: ether, thioether, carboxamide, thiourea, sulfonamide, urea, urethane, hydrazine, alkyl, aryl, heteroaryl, alkoxy, cycloalkyl and amine moieties.
  • Examples of a linker include substituted or unsubstituted polymethylene, arylene, alkylarylene, arylenealkyl, and arylthio.
  • the linker contains 1-6 carbon atoms; in another, the linker comprises a thioether linkage.
  • Exemplary linking members include a moiety that includes —C(O)NH—, —C(O)O—, —NH—, —S—, —O—, and the like.
  • the linker is or incorporates the formula —(CH 2 ) d (CONH(CH 2 ) e ) z — or where d is an integer from 0-5, e is an integer from 1-5 and z is 0 or 1.
  • the linker is or incorporates the formula —O—(CH 2 )—.
  • the linker is or incorporates a phenylene or a 2-carboxy-substituted phenylene.
  • linker An important feature of the linker is to provide an adequate space between the carrier molecule, reactive group or solid support and the dye so as to prevent steric hinderance. Therefore, the linker of the present compound is important for (1) attaching the carrier molecule, reactive group or solid support to the compound, (2) providing an adequate space between the carrier molecule, reactive group or solid support and the compound so as not to sterically hinder the action of the compound and (3) for altering the physical properties of the present compounds.
  • the present compounds are chemically reactive, and are substituted by at least one reactive group.
  • the reactive group functions as the site of attachment for another moiety, such as a carrier molecule or a solid support, wherein the reactive group chemically reacts with an appropriate reactive or functional group on the carrier molecule or solid support.
  • the compounds of the invention further comprise a reactive group which is a member selected from an acrylamide, an activated ester of a carboxylic acid, a carboxylic ester, an acyl azide, an acyl nitrile, an aldehyde, an alkyl halide, an anhydride, an aniline, an amine, an aryl halide, an azide, an aziridine, a boronate, a diazoalkane, a haloacetamide, a haloalkyl, a halotriazine, a hydrazine, an imido ester, an isocyanate, an isothiocyanate, a maleimide, a phosphoramidite, a photoactivatable group, a reactive platinum complex, a silyl halide, a sulfonyl halide, and a thiol.
  • a reactive group which is a member selected from an acrylamide, an
  • the reactive group is selected from the group consisting of carboxylic acid, succinimidyl ester of a carboxylic acid, hydrazide, amine and a maleimide.
  • at least one member selected from R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 is a reactive group.
  • the reactive group is bound to one of the aromatic carbons of the heterocycle ring systems formed when R 9 in combination with R 10 , or R 10 in combination with one of R 2 or R 7 ; or R 11 in combination with one of R 4 or R 5 forms a saturated or unsaturated 5- or 6-membered heterocycle.
  • the reactive group is bound to the compound of the invention at R 2 , R 3 , R 4 , R 5 , R 6 or R 7 .
  • the reactive group is bound to the dye moiety at R 2 , R 3 , R 4 , R 5 , or R 7 .
  • a reactive group may be covalently attached independently to those substituents, allowing for further conjugation to a another dye, carrier molecule or solid support.
  • the compound comprises at least one reactive group that selectively reacts with an amine group.
  • This amine-reactive group is selected from the group consisting of succinimidyl ester, sulfonyl halide, tetrafluorophenyl ester and iosothiocyanates.
  • the present compounds form a covalent bond with an amine-containing molecule in a sample.
  • the compound comprises at least one reactive group that selectively reacts with a thiol group. This thiol-reactive group is selected from the group consisting of maleimide, haloalkyl and haloacetamide (including any reactive groups disclosed in U.S. Pat. Nos. 5,362,628; 5,352,803 and 5,573,904).
  • reactive groups are synthesized during the formation of the dye and anthracene-containing compounds to provide dye, anthracene, and reactive group-containing compounds.
  • compounds incorporating a reactive group can be covalently attached to a wide variety of carrier molecules or solid supports that contain or are modified to contain functional groups with suitable reactivity, resulting in chemical attachment of the components.
  • the reactive group of the compounds of the invention and the functional group of the carrier molecule of solid support comprise electrophiles and nucleophiles that can generate a covalent linkage between them.
  • the reactive group comprises a photoactivatable group, which becomes chemically reactive only after illumination with light of an appropriate wavelength.
  • the conjugation reaction between the reactive group and the carrier molecule/solid support results in one or more atoms of the reactive group being incorporated into a new linkage attaching the dye/anthracene compound of the invention to the carrier molecule/solid support.
  • Selected examples of functional groups and linkages are shown in Table 1, where the reaction of an electrophilic group and a nucleophilic group yields a covalent linkage.
  • Choice of the reactive group used to attach the compound of the invention to the substance to be conjugated typically depends on the reactive or functional group on the substance to be conjugated and the type or length of covalent linkage desired.
  • the types of functional groups typically present on the organic or inorganic substances include, but are not limited to, amines, amides, thiols, alcohols, phenols, aldehydes, ketones, phosphates, imidazoles, hydrazines, hydroxylamines, disubstituted amines, halides, epoxides, silyl halides, carboxylate esters, sulfonate esters, purines, pyrimidines, carboxylic acids, olefinic bonds, or a combination of these groups.
  • a single type of reactive site may be available on the substance (typical for polysaccharides or silica), or a variety of sites may occur (e.g., amines, thiols, alcohols, phenols), as is typical for proteins.
  • the reactive group will react with an amine, a thiol, an alcohol, an aldehyde, a ketone, or with silica.
  • reactive groups react with an amine or a thiol functional group, or with silica.
  • the reactive group is an acrylamide, an activated ester of a carboxylic acid, an acyl azide, an acyl nitrile, an aldehyde, an alkyl halide, a silyl halide, an anhydride, an aniline, an aryl halide, an azide, an aziridine, a boronate, a diazoalkane, a haloacetamide, a halotriazine, a hydrazine (including hydrazides), an imido ester, an isocyanate, an isothiocyanate, a maleimide, a phosphoramidite, a reactive platinum complex, a sulfonyl halide, or a thiol group.
  • reactive platinum complex is particularly meant chemically reactive platinum complexes such as described in U.S. Pat. No. 5,714,327.
  • the reactive group is an activated ester of a carboxylic acid, such as a succinimidyl ester of a carboxylic acid, a sulfonyl halide, a tetrafluorophenyl ester or an isothiocyanates
  • the resulting compound is particularly useful for preparing conjugates of carrier molecules such as proteins, nucleotides, oligonucleotides, or haptens.
  • the reactive group is a maleimide, haloalkyl or haloacetamide (including any reactive groups disclosed in U.S. Pat. Nos.
  • the resulting compound is particularly useful for conjugation to thiol-containing substances.
  • the reactive group is a hydrazide
  • the resulting compound is particularly useful for conjugation to periodate-oxidized carbohydrates and glycoproteins, and in addition is an aldehyde-fixable polar tracer for cell microinjection.
  • the reactive group is a silyl halide
  • the resulting compound is particularly useful for conjugation to silica surfaces, particularly where the silica surface is incorporated into a fiber optic probe subsequently used for remote ion detection or quantitation.
  • the reactive group is a photoactivatable group such that the group is only converted to a reactive species after illumination with an appropriate wavelength.
  • An appropriate wavelength is generally a UV wavelength that is less than 400 nm. This method provides for specific attachment to only the target molecules, either in solution or immobilized on a solid or semi-solid matrix.
  • Photoactivatable reactive groups include, without limitation, benzophenones, aryl azides and diazirines.
  • the reactive group is, a photoactivatable group, succinimidyl ester of a carboxylic acid, a haloacetamide, haloalkyl, a hydrazine, an isothiocyanate, a maleimide group, an aliphatic amine, a silyl halide, a cadaverine or a psoralen. More preferably, the reactive group is a succinimidyl ester of a carboxylic acid, a maleimide, an iodoacetamide, or a silyl halide.
  • the reactive group is a succinimidyl ester of a carboxylic acid, a sulfonyl halide, a tetrafluorophenyl ester, an iosothiocyanates or a maleimide.
  • the dye/anthracene compound is covalently bound to a carrier molecule.
  • the carrier molecule can be attached to the compound through either the dye moiety or the anthracene moiety. If the compound has a reactive group, then the carrier molecule can alternatively be linked to the compound through the reactive group.
  • the reactive group may contain both a reactive functional moiety and a linker, or only the reactive functional moiety.
  • carrier molecules include antigens, steroids, vitamins, drugs, haptens, metabolites, toxins, environmental pollutants, amino acids, peptides, proteins, nucleic acids, nucleic acid polymers, carbohydrates, lipids, and polymers.
  • at least one member selected from R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 is a carrier molecule.
  • the carrier molecule is bound to one of the aromatic carbons of the heterocycle ring systems formed when R 9 in combination with R 10 , or R 10 in combination with one of R 2 or R 7 ; or R 11 in combination with one of R 4 or R 5 forms a saturated or unsaturated 5- or 6-membered heterocycle.
  • the carrier molecule is bound to the compound of the invention at R 2 , R 3 , R 4 , R 5 , R 6 or R 7 .
  • the carrier molecule is bound to the dye moiety at R 2 , R 3 , R 4 , R 5 , or R 7 .
  • a reactive group may be covalently attached independently to those substituents, allowing for further conjugation to a reactive group, carrier molecule or solid support.
  • the carrier molecule comprises an amino acid, a peptide, a protein, a polysaccharide, a nucleoside, a nucleotide, an oligonucleotide, a nucleic acid, a hapten, a psoralen, a drug, a hormone, a lipid, a lipid assembly, a synthetic polymer, a polymeric microparticle, a biological cell, a virus and combinations thereof.
  • the carrier molecule is selected from a hapten, a nucleotide, an oligonucleotide, a nucleic acid polymer, a protein, a peptide or a polysaccharide.
  • the carrier molecule is amino acid, a peptide, a protein, a polysaccharide, a nucleoside, a nucleotide, an oligonucleotide, a nucleic acid, a hapten, a psoralen, a drug, a hormone, a lipid, a lipid assembly, a tyramine, a synthetic polymer, a polymeric microparticle, a biological cell, cellular components, an ion chelating moiety, an enzymatic substrate or a virus.
  • the carrier molecule is an antibody or fragment thereof, an antigen, an avidin or streptavidin, a biotin, a dextran, an antibody binding protein, a fluorescent protein, agarose, and a non-biological microparticle.
  • the carrier molecule is an antibody, an antibody fragment, antibody-binding proteins, avidin, streptavidin, a toxin, a lectin, or a growth factor.
  • Preferred haptens include biotin, digoxigenin and fluorophores.
  • Antibody binging proteins include, but are not limited to, protein A, protein G, soluble Fc receptor, protein L, lectins, anti-IgG, anti-IgA, anti-IgM, anti-IgD, anti-IgE or a fragment thereof.
  • the enzymatic substrate is selected from an amino acid, peptide, sugar, alcohol, alkanoic acid, 4-guanidinobenzoic acid, nucleic acid, lipid, sulfate, phosphate, —CH 2 OCOalkyl and combinations thereof.
  • the enzyme substrates can be cleave by enzymes selected from the group consisting of peptidase, phosphatase, glycosidase, dealkylase, esterase, guanidinobenzotase, sulfatase, lipase, peroxidase, histone deacetylase, endoglycoceramidase, exonuclease, reductase and endonuclease.
  • the carrier molecule is an amino acid (including those that are protected or are substituted by phosphates, carbohydrates, or C 1 to C 22 carboxylic acids), or a polymer of amino acids such as a peptide or protein.
  • the carrier molecule contains at least five amino acids, more preferably 5 to 36 amino acids.
  • Exemplary peptides include, but are not limited to, neuropeptides, cytokines, toxins, protease substrates, and protein kinase substrates.
  • Other exemplary peptides may function as organelle localization peptides, that is, peptides that serve to target the conjugated compound for localization within a particular cellular substructure by cellular transport mechanisms.
  • Preferred protein carrier molecules include enzymes, antibodies, lectins, glycoproteins, histones, albumins, lipoproteins, avidin, streptavidin, protein A, protein G, phycobiliproteins and other fluorescent proteins, hormones, toxins and growth factors.
  • the protein carrier molecule is an antibody, an antibody fragment, avidin, streptavidin, a toxin, a lectin, or a growth factor.
  • Exemplary haptens include biotin, digoxigenin and fluorophores.
  • the carrier molecule comprises a nucleic acid base, nucleoside, nucleotide or a nucleic acid polymer, optionally containing an additional linker or spacer for attachment of a fluorophore or other ligand, such as an alkynyl linkage (U.S. Pat. No. 5,047,519), an aminoallyl linkage (U.S. Pat. No. 4,711,955) or other linkage.
  • the nucleotide carrier molecule is a nucleoside or a deoxynucleoside or a dideoxynucleoside.
  • nucleic acid polymer carrier molecules are single- or multi-stranded, natural or synthetic DNA or RNA oligonucleotides, or DNA/RNA hybrids, or incorporating an unusual linker such as morpholine derivatized phosphates (AntiVirals, Inc., Corvallis Oreg.), or peptide nucleic acids such as N-(2-aminoethyl)glycine units, where the nucleic acid contains fewer than 50 nucleotides, more typically fewer than 25 nucleotides.
  • an unusual linker such as morpholine derivatized phosphates (AntiVirals, Inc., Corvallis Oreg.)
  • peptide nucleic acids such as N-(2-aminoethyl)glycine units
  • the carrier molecule comprises a carbohydrate or polyol that is typically a polysaccharide, such as dextran, FICOLL, heparin, glycogen, amylopectin, mannan, inulin, starch, agarose and cellulose, or is a polymer such as a poly(ethylene glycol).
  • the polysaccharide carrier molecule includes dextran, agarose or FICOLL.
  • the carrier molecule comprises a lipid (typically having 6-25 carbons), including glycolipids, phospholipids, and sphingolipids.
  • the carrier molecule comprises a lipid vesicle, such as a liposome, or is a lipoprotein (see below). Some lipophilic substituents are useful for facilitating transport of the conjugated dye into cells or cellular organelles.
  • the carrier molecule is cells, cellular systems, cellular fragments, or subcellular particles.
  • this type of conjugated material include virus particles, bacterial particles, virus components, biological cells (such as animal cells, plant cells, bacteria, or yeast), or cellular components.
  • cellular components that can be labeled, or whose constituent molecules can be labeled, include but are not limited to lysosomes, endosomes, cytoplasm, nuclei, histones, mitochondria, Golgi apparatus, endoplasmic reticulum and vacuoles.
  • the carrier molecule is a metal chelating moiety. While any chelator that binds a metal ion of interest and gives a change in its fluorescence properties is a suitable conjugate, preferred metal chelating moieties are crown ethers, including diaryldiaza crown ethers, as described in U.S. Pat. No. 5,405,975 to Kuhn et al. (1995); derivatives of 1,2-bis-(2-aminophenoxyethane)-N,N,N′,N′-tetraacetic acid (BAPTA), as described in U.S. Pat. No. 5,453,517 to Kuhn et al. (1995) (incorporated by reference) and U.S. Pat. No.
  • Fluorescent conjugates of metal chelating moieties possess utility as indicators for the presence of a desired metal ion. While fluorescent ion-indicators are known in the art, the incorporation of the fluorinated fluorogenic and fluorescent compounds of the present invention imparts the highly advantageous properties of the instant fluorophores onto the resulting ion indicator.
  • the ion-sensing conjugates of the invention are optionally prepared in chemically reactive forms and further conjugated to polymers such as dextrans to improve their utility as sensors as described in U.S. Pat. Nos. 5,405,975 and 5,453,517.
  • the carrier molecule non-covalently associates with organic or inorganic materials.
  • exemplary embodiments of the carrier molecule that possess a lipophilic substituent can be used to target lipid assemblies such as biological membranes or liposomes by non-covalent incorporation of the dye compound within the membrane, e.g., for use as probes for membrane structure or for incorporation in liposomes, lipoproteins, films, plastics, lipophilic microspheres or similar materials.
  • the carrier molecule comprises a specific binding pair member wherein the present compounds are conjugated to a specific binding pair member and are used to detect an analyte in a sample.
  • the presence of the labeled specific binding pair member indicates the location of the complementary member of that specific binding pair; each specific binding pair member having an area on the surface or in a cavity which specifically binds to, and is complementary with, a particular spatial and polar organization of the other.
  • Exemplary binding pairs are set forth in Table 2.
  • IgG antigen antibody biotin avidin (or streptavidin or anti-biotin) IgG* protein A or protein G drug drug receptor folate folate binding protein toxin toxin receptor carbohydrate lectin or carbohydrate receptor peptide peptide receptor protein protein receptor enzyme substrate enzyme DNA (RNA) cDNA (cRNA) ⁇ hormone hormone receptor ion chelator antibody antibody-binding proteins *IgG is an immunoglobulin ⁇ cDNA and cRNA are the complementary strands used for hybridization
  • the present compounds of the invention are covalently bonded to a solid support.
  • the solid support may be attached to the compound or through a reactive group, if present, or through a carrier molecule, if present. Even if a reactive group and/or a carrier molecule are present, the solid support may be attached through R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 is a reactive group.
  • the solid support is bound to one of the aromatic carbons of the heterocycle ring systems formed when R 9 in combination with R 10 , or R 10 in combination with one of R 2 or R 7 ; or R 11 in combination with one of R 4 or R 5 forms a saturated or unsaturated 5- or 6-membered heterocycle.
  • the solid support is bound to the compound of the invention at R 2 , R 3 , R 4 , R 5 , R 6 or R 7 .
  • the solid support is bound to the dye moiety at R 2 , R 3 , R 4 , R 5 , or R 7 .
  • a solid support may be covalently attached independently to those substituents, allowing for further conjugation to a another dye, carrier molecule or solid support.
  • a solid support suitable for use in the present invention is typically substantially insoluble in liquid phases.
  • Solid supports of the current invention are not limited to a specific type of support. Rather, a large number of supports are available and are known to one of ordinary skill in the art.
  • useful solid supports include solid and semi-solid matrixes, such as aerogels and hydrogels, resins, beads, biochips (including thin film coated biochips), microfluidic chip, a silicon chip, multi-well plates (also referred to as microtitre plates or microplates), membranes, conducting and nonconducting metals, glass (including microscope slides) and magnetic supports.
  • useful solid supports include silica gels, polymeric membranes, particles, derivatized plastic films, glass beads, cotton, plastic beads, alumina gels, polysaccharides such as Sepharose, poly(acrylate), polystyrene, poly(acrylamide), polyol, agarose, agar, cellulose, dextran, starch, FICOLL, heparin, glycogen, amylopectin, mannan, inulin, nitrocellulose, diazocellulose, polyvinylchloride, polypropylene, polyethylene (including poly(ethylene glycol)), nylon, latex bead, magnetic bead, paramagnetic bead, superparamagnetic bead, starch and the like.
  • polysaccharides such as Sepharose, poly(acrylate), polystyrene, poly(acrylamide), polyol, agarose, agar, cellulose, dextran, starch, FICOLL, heparin, glycogen, amylopectin,
  • the solid support may include a solid support reactive functional group, including, but not limited to, hydroxyl, carboxyl, amino, thiol, aldehyde, halogen, nitro, cyano, amido, urea, carbonate, carbamate, isocyanate, sulfone, sulfonate, sulfonamide, sulfoxide, etc., for attaching the compounds of the invention.
  • a solid support reactive functional group including, but not limited to, hydroxyl, carboxyl, amino, thiol, aldehyde, halogen, nitro, cyano, amido, urea, carbonate, carbamate, isocyanate, sulfone, sulfonate, sulfonamide, sulfoxide, etc.
  • a suitable solid phase support can be selected on the basis of desired end use and suitability for various synthetic protocols.
  • resins generally useful in peptide synthesis may be employed, such as polystyrene (e.g., PAM-resin obtained from Bachem Inc., Peninsula Laboratories, etc.), POLYHIPETM resin (obtained from Aminotech, Canada), polyamide resin (obtained from Peninsula Laboratories), polystyrene resin grafted with polyethylene glycol (TentaGelTM, Rapp Polymere, Tubingen, Germany), polydimethyl-acrylamide resin (available from Milligen/Biosearch, California), or PEGA beads (obtained from Polymer Laboratories).
  • polystyrene e.g., PAM-resin obtained from Bachem Inc., Peninsula Laboratories, etc.
  • POLYHIPETM resin obtained from Aminotech, Canada
  • polyamide resin obtained from Peninsula Laboratories
  • polystyrene resin grafted with polyethylene glycol Te
  • Conjugates of components are prepared by organic synthesis methods using the reactive reporter molecules of the invention, are generally prepared by means well recognized in the art (Haugland, MOLECULAR PROBES HANDBOOK, supra, (2002)).
  • conjugation to form a covalent bond consists of simply mixing the reactive compounds of the present invention in a suitable solvent in which both the reactive compound and the substance to be conjugated are soluble. The reaction preferably proceeds spontaneously without added reagents at room temperature or below. For those reactive compounds that are photoactivated, conjugation is facilitated by illumination of the reaction mixture to activate the reactive compound.
  • Preparation of peptide or protein conjugates typically comprises first dissolving the protein to be conjugated in aqueous buffer at about 1-10 mg/mL at room temperature or below.
  • Bicarbonate buffers pH about 8.3 are especially suitable for reaction with succinimidyl esters, phosphate buffers (pH about 7.2-8) for reaction with thiol-reactive functional groups and carbonate or borate buffers (pH about 9) for reaction with isothiocyanates and dichlorotriazines.
  • the appropriate reactive compound is then dissolved in an aprotic solvent (usually DMSO or DMF) in an amount sufficient to give a suitable degree of labeling when added to a solution of the protein to be conjugated.
  • the appropriate amount of compound for any protein or other component is conveniently predetermined by experimentation in which variable amounts of the compound are added to the protein, the conjugate is chromatographically purified to separate unconjugated compound and the compound-protein conjugate is tested in its desired application.
  • suitable conjugates can be prepared from antibodies, antibody fragments, avidins, lectins, enzymes, proteins A and G, cellular proteins, albumins, histones, growth factors, hormones, and other proteins.
  • Conjugates of polymers are typically prepared by means well recognized in the art (for example, Brinkley et al., Bioconjugate Chem., 3: 2 (1992)).
  • a single type of reactive site may be available, as is typical for polysaccharides) or multiple types of reactive sites (e.g. amines, thiols, alcohols, phenols) may be available, as is typical for proteins.
  • Selectivity of labeling is best obtained by selection of an appropriate reactive dye.
  • thiols For example, modification of thiols with a thiol-selective reagent such as a haloacetamide or maleimide, or modification of amines with an amine-reactive reagent such as an activated ester, acyl azide, isothiocyanate or 3,5-dichloro-2,4,6-triazine. Partial selectivity can also be obtained by careful control of the reaction conditions.
  • a thiol-selective reagent such as a haloacetamide or maleimide
  • modification of amines with an amine-reactive reagent such as an activated ester, acyl azide, isothiocyanate or 3,5-dichloro-2,4,6-triazine. Partial selectivity can also be obtained by careful control of the reaction conditions.
  • an excess of compound is typically used, relative to the expected degree of compound substitution.
  • Any residual, unreacted compound or a compound hydrolysis product is typically removed by dialysis, chromatography or precipitation. Presence of residual, unconjugated dye can be detected by thin layer chromatography using a solvent that elutes the dye away from its conjugate. In all cases it is usually preferred that the reagents be kept as concentrated as practical so as to obtain adequate rates of conjugation.
  • the conjugate of the invention is associated with an additional substance, that binds either to the reporter molecule or the conjugated substance (carrier molecule or solid support) through noncovalent interaction.
  • the additional substance is an antibody, an enzyme, a hapten, a lectin, a receptor, an oligonucleotide, a nucleic acid, a liposome, or a polymer.
  • the additional substance is optionally used to probe for the location of the dye-conjugate, for example, as a means of enhancing the signal of the dye-conjugate.
  • the compounds of the invention are synthesized by an appropriate combination of generally well known synthetic methods. Techniques useful in synthesizing the compounds of the invention are both readily apparent and accessible to those of skill in the relevant art. The discussion below is offered to illustrate certain of the diverse methods available for use in assembling the compounds of the invention; it is not intended to define the scope of reactions or reaction sequences that are useful in preparing the compounds of the present invention.
  • Alkyl anthracene 1 is brominated in CCl 4 in order to form 2 (reaction a).
  • 2 is combined with 2,4-dimethyloxyphenyl boronic acid and tetrakis(triphenylphosphine)palladium in toluene to yield 3 (reaction b).
  • the protecting groups are removed from 3 with BBr 3 in CH 2 Cl 2 in order to form 4 (reaction c).
  • Anthracene-9carboxylic acid 13 is reacted with oxalyl chloride, and then allylic amine in dry DMF/CH 2 Cl 2 in order to produce 14 (reaction 1).
  • 14 is reacted with phosgene and then reacted under basic conditions to produce 15 (reaction m).
  • 15 is then reacted with 3,5 dimethylpyrrole-2-carboxaldehyde and phosphorus oxychloride in dry CH 2 Cl 2 .
  • Diisopropyl ethyl amine and boron-trifluoride diethyl ether complex are then added in order to produce 16 (reaction n).
  • the present invention also provides methods of using the compounds described herein for a wide variety of chemical, biological and biochemical applications.
  • the present invention provides a method for determining the presence of singlet oxygen in a sample.
  • the method includes contacting the sample with a compound of the invention that is not already oxidized.
  • the singlet oxygen is allowed to react with the compound of the invention to form a fluorescent product.
  • the method further comprises illuminating the fluorescent product with an appropriate wavelength so that the presence of the singlet oxygen is determined in the sample.
  • the present method for detecting the presence or absence of singlet oxygen in a sample comprises:
  • the present invention provides a method of detecting singlet oxygen in a sample by using an immobilized compound of the invention.
  • the method includes combining the sample with a compound of the invention covalently bonded to a solid support.
  • the singlet oxygen in the sample is then allowed to react with the compound of the invention to form a fluorescent product.
  • the method further comprises illuminating the fluorescent product with an appropriate wavelength so that the presence of the singlet oxygen is determined in the sample.
  • the methods may further include, after forming the fluorescent product, rinsing the solid support to remove components of the sample other than the immobilized fluorescent product.
  • the methods may further provide, after forming the immobilized fluorescent product, detecting the immobilized fluorescent product.
  • the immobilized fluorescent product is detected after rinsing the solid support.
  • the method may further provide, after forming the immobilized fluorescent product, releasing the singlet oxygen in the immobilized fluorescent product with a reducing agent.
  • Solid supports covalently bonded to a compound of the invention are discussed in detail above and are equally applicable to the methods discussed herein.
  • carrier molecules covalently bonded to a compound of the invention are discussed in detail above and are equally applicable to the methods discussed herein.
  • Rinsing the solid support typically functions to remove residual, excess or unbound materials from the solid support other than the immobilized fluorescent product. Any appropriate solution or series or solutions may be used to rinse the solid support. Exemplary solvents useful in the present invention include both polar and non-polar solvents. Thus, any appropriate organic solvent or aqueous solution is useful in the methods of the current invention.
  • Solutions of the compounds of the invention are prepared according to methods generally known in the art.
  • the compounds of the invention are generally soluble in water and aqueous solutions having a pH less than or equal to about 6.
  • Stock solutions of pure compounds of the invention may be dissolved in organic solvent before diluting into aqueous solution or buffer.
  • organic solvents are aprotic polar solvents such as DMSO, DMF, N-methylpyrrolidone, acetone, acetonitrile, dioxane, tetrahydrofuran and other nonhydroxylic, completely water-miscible solvents.
  • the amount of compounds of the invention in solution is the minimum amount required to yield detectable singlet oxygen presence within a reasonable time, with minimal background signal.
  • concentration of compound of the invention to be used is dependent upon the experimental conditions and the desired results, and optimization of experimental conditions is typically required to determine the best concentration to be used in a given application.
  • concentration typically ranges from nanomolar to micromolar.
  • the required concentration is determined by systematic variation in compound concentration until satisfactory results are accomplished.
  • the starting ranges are readily determined from methods known in the art for use of similar compounds under comparable conditions for the desired response.
  • the compounds of the invention are optionally introduced into living cells by passive permeation through the cellular membranes.
  • cell-permeant embodiments of the invention are optionally introduced into cells by pressure microinjection methods, scrape loading techniques (short mechanical disruption of the plasma membrane where the plasma membrane is peeled away from the cytoplasm, the compound is perfused through the sample and the plasma membrane is reassembled), patch clamp methods (where an opening is maintained in the plasma membrane for long periods) or phagocytosis. Any other treatment that will permeabilize the plasma membrane, such as electroporation, shock treatments or high extracellular ATP can be used to introduce the compounds into the cellular cytoplasm.
  • detection is achieved by illuminating the fluorogenic or fluorescent compounds at a wavelength selected to elicit a detectable optical response.
  • a detectable optical response means a change in, or occurrence of, a parameter in a test system that is capable of being perceived, either by direct observation or instrumentally.
  • the detectable response is a change in fluorescence, such as a change in the intensity, excitation or emission wavelength distribution of fluorescence, fluorescence lifetime, fluorescence polarization, or a combination thereof.
  • the detectable optical response may occur throughout the sample or in a localized portion of the sample.
  • the presence or absence of the optical response after the elapsed time is indicative of one or more characteristic of the sample. Comparison of the amount of the compound of the invention with a standard or expected response can be used to determine whether and to what degree a sample possesses singlet oxygen.
  • the compounds of the invention are useful as coloring agents, tracers for detecting the flow of fluids such as in angiography, and tracing of fluid flow through gap junctions of neurons according to procedures known in the art for other dyes.
  • the compounds of the invention are also useful in assays as haptens, according to known methods.
  • the dye solution comprises a chemically reactive dye that is used to chemically attach the dye to the corresponding functional group on any of a wide variety of materials, such as cells, tissues, proteins, antibodies, enzymes, drugs, hormones, lipids, nucleotides, nucleic acids, or natural or synthetic polymers.
  • the compounds of the invention are also of use in numerous fluorescence polarization assays.
  • the amount of the compound that fluoresces functions as an indicator of the ion, which indicators are optionally further conjugated to a biological or plastic polymer according to methods known in the art; e.g., using fluorinated analogs of the compounds described in U.S. Pat. Nos. 5,453,517 and 5,405,975.
  • the compound of the invention acts as a pH indicator at pH values within about 1.5 pH units of the individual dye's pKa.
  • the detectable optical response of the ion indicators is a change in fluorescence of the ion chelator.
  • the sample and/or fluorogenic compounds are illuminated with a wavelength of light selected to give a detectable optical response, and observed with a means for detecting the optical response.
  • Equipment that is useful for illuminating the present compounds and compositions of the invention includes, but is not limited to, hand-held ultraviolet lamps, mercury arc lamps, xenon lamps, lasers and laser diodes. These illumination sources are optically integrated into laser scanners, fluorescence microplate readers or standard or microfluorometers.
  • the compounds of the invention may, at any time after or during an assay, be illuminated with a wavelength of light that results in a detectable optical response, and observed with a means for detecting the optical response.
  • a wavelength of light that results in a detectable optical response
  • the fluorescent compounds including those bound to the complementary specific binding pair member, display intense visible absorption as well as fluorescence emission.
  • Selected equipment that is useful for illuminating the fluorescent compounds of the invention includes, but is not limited to, hand-held ultraviolet lamps, mercury arc lamps, xenon lamps, argon lasers, laser diodes, and YAG lasers.
  • illumination sources are optionally integrated into laser scanners, fluorescence microplate readers, standard or mini fluorometers, or chromatographic detectors.
  • This fluorescence emission is optionally detected by visual inspection, or by use of any of the following devices: CCD cameras, video cameras, photographic film, laser scanning devices, fluorometers, photodiodes, quantum counters, epifluorescence microscopes, scanning microscopes, flow cytometers, fluorescence microplate readers, or by means for amplifying the signal such as photomultiplier tubes.
  • the instrument is optionally used to distinguish and discriminate between the fluorescent compounds of the invention and a second fluorophore with detectably different optical properties, typically by distinguishing the fluorescence response of the fluorescent compounds of the invention from that of the second fluorophore.
  • examination of the sample optionally includes isolation of particles within the sample based on the fluorescence response by using a sorting device.
  • the end user will determine the choice of the sample and the way in which the sample is prepared.
  • the sample includes, without limitation, any biological derived material that is thought to contain singlet oxygen.
  • samples also include material in which singlet oxygen has been added to determine the effect that singlet oxygen has on predetermined biological parameters.
  • the sample can also include a buffer solution that contains any of the quencher compositions of the present invention to determine the ability of the carbocyanine compounds to quench the donor signal or the ability to reduce the residual energy from the donor molecule in the absence of a fluorogenic compound of the invention.
  • the sample can be a biological fluid such as whole blood, plasma, serum, nasal secretions, sputum, saliva, urine, sweat, transdermal exudates, cerebrospinal fluid, or the like.
  • Biological fluids also include tissue and cell culture medium wherein an analyte of interest has been secreted into the medium.
  • the sample may be whole organs, tissue or cells from the animal. Examples of sources of such samples include muscle, eye, skin, gonads, lymph nodes, heart, brain, lung, liver, kidney, spleen, thymus, pancreas, solid tumors, macrophages, mammary glands, mesothelium, and the like.
  • Cells include without limitation prokaryotic cells and eukaryotic cells that include primary cultures and immortalized cell lines.
  • Eukaryotic cells include without limitation ovary cells, epithelial cells, circulating immune cells, ⁇ cells, hepatocytes, and neurons.
  • non-ionic detergent it may be advantageous to add a small amount of a non-ionic detergent to the sample.
  • the detergent will be present in from about 0.01 to 0.1 vol. %.
  • illustrative non-ionic detergents include the polyoxyalkylene diols, e.g. Pluronics, Tweens, Triton X-100, etc.
  • the reaction is optionally quenched.
  • Various quenching agents may be used, both physical and chemical.
  • a small amount of a water-soluble solvent may be added, such as acetonitrile, DMSO, SDS, methanol, DMF, etc.
  • the methods of the invention further comprise producing singlet oxygen through a generation system.
  • the singlet oxygen is generated from a reaction which is a member selected from a photosensitizer and ground state oxygen in the presence of visible light (such as chlorophyl, hematoporphyin, Rose Bengal, eosin and the like, as described by A. Nickon and W. L. Mendelson, J. Am. Chem. Soc. 87: 3921 (1965) and K. Gollnick and G. O. Schenk, Pure and Applied Chem., 9:507 (1964), or as described in U.S. Pat. No. 3,281,415); hypochlorites and hydrogen peroxide (C. S. Foote and S.
  • singlet oxygen is a product formed by the reaction of a photosensitizer and ground state oxygen in the presence of visible light.
  • the photosensitizer is a member selected from aromatic carbonyl compounds, condensed aromatic compounds, acridine dyes, coumarin dyes, crystal violet, fluorene derivatives, naphthalocyanines, porphyrin derivatives, chlorins, phthalocyanines, thiazine dyes, thioketones, xanthene dyes, platinum (II) terpyridyl acetylide complex, and combinations thereof.
  • the photosensitizer is a member selected from acetonapthone, acetophenone, benzophenone, acridine orange, eosin, fluorene, fluorenone, fluorescein, methylene blue, naphthalocyanines, phthalocyanine, rose bengal, 5,10,15,20-tetrakis(m-hydroxyphenyl)chlorin, thiocoumarin, toluidine blue, methylene blue, zinc tetraphenylporphyrin tetrasulfonate, and combinations thereof.
  • the photosensitizer is methylene blue.
  • singlet oxygen is a product formed by the reaction of sodium molybdate and hydrogen peroxide.
  • Light is required for the photochemical generation of singlet oxygen.
  • the light source is preferably sunlight or room light such as incandescent or fluorescent light.
  • Coherent or narrow spectrum sources such as lasers and light emitting diodes, flash tubes, arc lamps, mercury vapor lamps, sodium lamps and other sources that will be familiar to those skilled in the art can also be employed, so long as the chosen light source provides the desired degree of singlet oxygen generation and safety under the desired conditions of use.
  • the light source provides both UV and visible energy. For many applications, the light from a typical 60 W to 100 W incandescent bulb, placed within a few centimeters of the desired target area, will provide sufficient illumination.
  • the intensity of illumination can vary within wide limits, depending in part on the type and concentration of sensitizer.
  • the exposure time can also vary, with exposure times of a few minutes up to a few hours being preferred and exposure times of a few minutes to about one hour being more preferred. As those skilled in the art will appreciate, use of lower intensity illumination or a greater distance between the light source and the antimicrobial composition will typically require a longer exposure time.
  • kits that include compounds of the invention, and a reaction buffer.
  • the kit will generally also include instructions for using the compound of the invention in one or more methods.
  • the kit further comprises a singlet oxygen generator as a positive control.
  • the singlet oxygen generator is a member selected from methylene blue/ground state oxygen/visible light, and sodium molybdate/hydrogen peroxide.
  • the kit in another exemplary embodiment, includes a solid support covalently bonded to a compound of the invention and instructions for immobilizing a target analyte in a sample to the solid support.
  • the instructions further specify, after forming the immobilized target analyte, rinsing the solid support to remove components of the sample other than the immobilized target analyte. In another related embodiment, the instructions further specify, after forming the immobilized target analyte, detecting the immobilized target analyte. In another related embodiment, the instructions further specify, after forming the immobilized target analyte, releasing the immobilized target analyte with a reducing agent.
  • kits and kit components can be prepared according to the present invention, depending upon the intended user of the kit, and the particular needs of the user.
  • succinimidyl trifluoroacetate 160 mg, 0.7 mmol.
  • the mixture was stirred at room temperature for 3 hrs.
  • the mixture was diluted with EtOAc and washed with H 2 O, 2% HCl and saturated NaCl.
  • the organic layer was concentrated to dryness in vacuo. The residue was dissolved in minimum amount of EtOAc and precipitation with hexanes to yield 9 (70 mg).
  • allyl amine (21 mL, 280 mmol) was dissolved in 100 mL dry methylene chloride (100 mL) under nitrogen, cooled to 0° C. and stirred for 15 minutes.
  • the anthracene acid chloride solution was added to the allyl amine at 0° C. under nitrogen.
  • the combined solution was stirred at 0° C. for 30 minutes.
  • the solution was carefully added to 1 M HCl (150 mL) and stirred overnight.
  • the biphasic mixture was partitioned and the aqueous portion was discarded.
  • the organic portion was placed in a freezer to crystallize.
  • the resultant crystals were collected by vacuum filtration and dried under vacuum for 48 hrs to give 14 (17.35 g)
  • the suspension was stirred for 30 minutes and nearly all suspended materials dissolved.
  • the THF-anthracene solution was added to the butoxide via syringe at 0° C. The resultant dark red solution was stirred for 30 min.
  • the THF was removed in vacuo and water (150 mL) added.
  • the mixture was extracted with ethyl acetate (2 ⁇ 50 mL).
  • the combined extracts were washed with brine, dried over sodium sulfate, filtered and dried to an oil.
  • the oil was purified by silica gel chromatography on silica gel (1:4 EtOAc/Hexanes) to yield 15 (532 mg).
  • the resultant solution was allowed to warm to room temperature and stirred for 2 hrs.
  • the solution was poured into pH 4.2 phosphate buffer solution (100 mL) and extracted with methylene chloride (2 ⁇ 50 mL). The combined organics were washed with brine, dried over sodium sulfate, filtered and dried to a reddish-brown solid.
  • Stock solutions of sodium molybdate (200 mM) and 40 ⁇ M dye Compound 5 or 6 were prepared in 100 mM phosphate buffer, pH 10).
  • Working solutions containing 2 mL of 1 ⁇ M dye and 20 mM H 2 O 2 in the same buffer were prepared in a 10 mm ⁇ 10 mm fluorescence cuvette.
  • the sample was placed in a Hitachi F-4500 spectrofluorometer and magnetic stirring was applied. Fluorescence measurements were made for periods of 20 seconds with 240 second (4 minute) intervals between each measurement. Fluorescence excitation and emission wavelength settings were 488 nm and 525 nm respectively. After the first measurement period, 1 mM NaMoO 4 was added to the sample.
  • the resulting fluorescence intensity versus time trace is labeled “pH 7.5” in FIG. 2 .
  • the experiment was repeated using a sample to which the 102 scavenger sodium azide (1 mM) had been added (trace labeled “NaN 3 ” in FIG. 2 ).
  • a third experiment was run in which 50% of the H 2 O content of the sample was replaced by D 2 O (trace labeled “50% D 2 O” in FIG. 2 ).
  • D 2 O has the effect of increasing the lifetime of 102. No irradiation-dependent increase of fluorescence intensity was observed for a control sample without methylene blue subjected to the same periodic laser exposure sequence.
  • a solution of Compound 5 (1 ⁇ M) was prepared in phosphate-buffered saline (PBS) (50 mM phosphate buffer, pH 7.4, 150 mM NaCl). A 2 mL portion of this solution was transferred to a 10 mm ⁇ 10 mm quartz cuvette. The fluorescence emission spectrum of the solution was recorded on a Hitachi F-4500 spectrofluorometer using excitation at 488 nm. 1 ⁇ L of a 4.5 mM solution of bovine serum albumin (30% (w/v) BSA (Sigma Chemical Co., St. Louis, Mo., catalog number A-7284)) was then added to the 2 mL of aqueous dye solution. The emission scan measurement was then repeated. Further measurements were made as the amount of added BSA was increased up to 4.5 ⁇ M. The observed increases in fluorescence intensity as a function of BSA concentration are plotted in FIG. 4 .
  • PBS phosphate-buffered saline
  • a solution of Compound 5 (1 ⁇ M) was prepared in dimethylsulfoxide (DMSO). A 2 mL portion of this solution was transferred to a 10 mm ⁇ 10 mm quartz cuvette. The fluorescence emission spectrum of the solution was recorded on a Hitachi F-4500 spectrofluorometer using excitation at 488 nm. 2 ⁇ L of water was then mixed into the 2 mL of DMSO solution. The emission scan measurement was then repeated. Further measurements were made as the fraction of water in the solvent was increased up to 10% (v/v). Results are plotted in FIG. 5A and FIG. 5B . Fluorescence intensities shown in these figures are not corrected for the relatively small (maximum 10%) dilution of the sample resulting from the addition of water.
US10/993,908 2003-11-19 2004-11-19 Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection Abandoned US20050214807A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/993,908 US20050214807A1 (en) 2003-11-19 2004-11-19 Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection
US12/040,850 US8173698B2 (en) 2003-11-19 2008-02-29 Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52374903P 2003-11-19 2003-11-19
US10/993,908 US20050214807A1 (en) 2003-11-19 2004-11-19 Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/040,850 Continuation US8173698B2 (en) 2003-11-19 2008-02-29 Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection

Publications (1)

Publication Number Publication Date
US20050214807A1 true US20050214807A1 (en) 2005-09-29

Family

ID=34990418

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/993,908 Abandoned US20050214807A1 (en) 2003-11-19 2004-11-19 Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection
US12/040,850 Expired - Fee Related US8173698B2 (en) 2003-11-19 2008-02-29 Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/040,850 Expired - Fee Related US8173698B2 (en) 2003-11-19 2008-02-29 Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection

Country Status (1)

Country Link
US (2) US20050214807A1 (US20050214807A1-20050929-C00024.png)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070134161A1 (en) * 2004-06-01 2007-06-14 Brown Milton L Methods of determining beta-iii tubulin expression
US20070141658A1 (en) * 2005-10-27 2007-06-21 The Regents Of The University Of California Fluorogenic probes for reactive oxygen species
WO2008118254A2 (en) * 2007-01-29 2008-10-02 Michigan Molecular Institute Remote laser interrogation of threat clouds and surfaces
WO2009048525A2 (en) * 2007-10-05 2009-04-16 Hercules Incorporated Selectivity improvement in oxygen delignification and bleaching of lignocellulose pulp using singlet oxygen
WO2007050810A3 (en) * 2005-10-27 2009-04-30 Univ California Fluorogenic probes for reactive oxygen species
WO2009121247A1 (en) 2008-04-05 2009-10-08 Versitech Limited Luminescence quenchers and fluorogenic probes for detection of reactive species
WO2009152102A2 (en) * 2008-06-10 2009-12-17 The Regents Of The University Of California Pro-fluorescent probes
US20110015529A1 (en) * 2006-03-31 2011-01-20 Mauna Kea Technologies Methylene blue based fibred fluorescence microscopy
CN102344464A (zh) * 2011-07-20 2012-02-08 北京师范大学 高水溶性钌金属配合物单线态氧荧光探针及其制备和应用
US20130171027A1 (en) * 2011-12-29 2013-07-04 Honeywell International Inc. Oxygen sensors based on hard-soft acid-base relationships
CN103554126A (zh) * 2013-11-15 2014-02-05 西安石油大学 油田用示踪剂的荧光素衍生物制备方法与应用
CN103755672A (zh) * 2014-01-26 2014-04-30 大连理工常熟研究院有限公司 一种用于识别半胱氨酸的特异性荧光探针及其应用
CN105334170A (zh) * 2015-06-11 2016-02-17 北京市环境保护监测中心 大气颗粒物表面有机活性物质的检测方法
CN109251206A (zh) * 2018-09-21 2019-01-22 上海大学 水溶性铂-卟啉配合物及其制备方法
CN110003355A (zh) * 2019-04-12 2019-07-12 安徽大学 一种具有aie特征的葡聚糖衍生物及其合成方法和用途
US10809242B2 (en) * 2014-05-19 2020-10-20 Technion Research & Development Foundation Limited Method for detection of an analyte/explosive on a sample surface
CN113999247A (zh) * 2021-11-03 2022-02-01 安徽理工大学 一种荧光酮类试剂的制备方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110111515A1 (en) * 2008-02-29 2011-05-12 The University Of Tokyo Reagent for measurement of reactive oxygen
CN103421030B (zh) * 2013-06-25 2015-10-07 河南大学 用作镉离子荧光探针的二元芳香酸铈配合物及其制备方法
CN103969232A (zh) * 2014-04-03 2014-08-06 浙江大学 一种三色荧光标记筛选抗阿霉素肾毒性活性物质的方法
CN104974744B (zh) * 2014-04-08 2017-01-04 深圳市汉康科技有限公司 一种硫氧还蛋白还原酶荧光探针及其制备方法和用途
CN105424670B (zh) * 2016-01-04 2018-05-25 贵州大学 一种检测溶液或细胞中10-7～10-5m低浓度h2o2的方法
WO2017123800A1 (en) * 2016-01-12 2017-07-20 The Regents Of University Of California Protein interactor detection systems
CN105732919A (zh) * 2016-03-25 2016-07-06 同济大学 一种含卟啉的温度及多种金属离子双重响应性嵌段共聚物凝胶的制备方法
CN109535114B (zh) * 2018-12-27 2020-11-20 浙江工业大学 一种对NaClO敏感的荧光化合物及其制备与应用
CN109928912B (zh) * 2019-01-29 2022-05-17 贵州大学 一种识别汞离子的荧光探针及其制备和识别方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525088B1 (en) * 1998-03-31 2003-02-25 Tetsuo Nagano Agent for measurement of singlet oxygen

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3281415A (en) * 1963-08-30 1966-10-25 Upjohn Co Steroidal delta16-20 (alpha and beta)-hydroperoxides
US3274181A (en) * 1964-09-18 1966-09-20 Univ California Process for oxygenation of organic compounds
US4711955A (en) * 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
US5171534A (en) * 1984-01-16 1992-12-15 California Institute Of Technology Automated DNA sequencing technique
US4603209A (en) * 1984-09-07 1986-07-29 The Regents Of The University Of California Fluorescent indicator dyes for calcium ions
US4812409A (en) * 1986-01-31 1989-03-14 Eastman Kodak Company Hydrolyzable fluorescent substrates and analytical determinations using same
US5268486A (en) * 1986-04-18 1993-12-07 Carnegie-Mellon Unversity Method for labeling and detecting materials employing arylsulfonate cyanine dyes
US5627027A (en) * 1986-04-18 1997-05-06 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
US6048982A (en) * 1986-04-18 2000-04-11 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
US5569587A (en) * 1986-04-18 1996-10-29 Carnegie Mellon University Method for labeling and detecting materials employing luminescent arysulfonate cyanine dyes
US5047519A (en) * 1986-07-02 1991-09-10 E. I. Du Pont De Nemours And Company Alkynylamino-nucleotides
CA1340806C (en) * 1986-07-02 1999-11-02 James Merrill Prober Method, system and reagents for dna sequencing
US4810636A (en) * 1986-12-09 1989-03-07 Miles Inc. Chromogenic acridinone enzyme substrates
US4945171A (en) * 1987-08-10 1990-07-31 Molecular Probes, Inc. Xanthene dyes having a fused (C) benzo ring
US4774339A (en) * 1987-08-10 1988-09-27 Molecular Probes, Inc. Chemically reactive dipyrrometheneboron difluoride dyes
US5049673A (en) * 1987-10-30 1991-09-17 The Regents Of The University Of California Fluorescent indicator dyes for calcium working at long wavelengths
US4849362A (en) * 1988-05-19 1989-07-18 Smithkline Beckman Corporation Fluorescent intracellular calcium indicators
US4997928A (en) * 1988-09-15 1991-03-05 E. I. Du Pont De Nemours And Company Fluorescent reagents for the preparation of 5'-tagged oligonucleotides
US5433896A (en) * 1994-05-20 1995-07-18 Molecular Probes, Inc. Dibenzopyrrometheneboron difluoride dyes
US5405975A (en) * 1993-03-29 1995-04-11 Molecular Probes, Inc. Fluorescent ion-selective diaryldiaza crown ether conjugates
US5227487A (en) * 1990-04-16 1993-07-13 Molecular Probes, Inc. Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes
US5648270A (en) * 1995-02-06 1997-07-15 Molecular Probes, Inc. Methods of sensing with fluorescent conjugates of metal-chelating nitrogen heterocycles
US5274113A (en) * 1991-11-01 1993-12-28 Molecular Probes, Inc. Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
US5453517A (en) * 1992-02-25 1995-09-26 Molecular Probes, Inc. Reactive derivatives of bapta used to make ion-selective chelators
US5459276A (en) * 1994-05-20 1995-10-17 Molecular Probes, Inc. Benzazolylcoumarin-based ion indicators for heavy metals
US5501980A (en) * 1994-05-20 1996-03-26 Molecular Probes, Inc. Benzazolylcoumarin-based ion indicators
US5714327A (en) * 1990-07-19 1998-02-03 Kreatech Diagnostics Platinum-containing compounds, methods for their preparation and applications thereof
US5248782A (en) * 1990-12-18 1993-09-28 Molecular Probes, Inc. Long wavelength heteroaryl-substituted dipyrrometheneboron difluoride dyes
US5451343A (en) * 1991-05-20 1995-09-19 Spectra Group Limited, Inc. Fluorone and pyronin y derivatives
US5187288A (en) * 1991-05-22 1993-02-16 Molecular Probes, Inc. Ethenyl-substituted dipyrrometheneboron difluoride dyes and their synthesis
US5242805A (en) * 1991-08-23 1993-09-07 Molecular Probes, Inc. Long wavelength lipophilic fluorogenic glycosidase substrates
WO1993004192A1 (en) * 1991-08-23 1993-03-04 Molecular Probes, Inc. Use of haloalkyl derivatives of reporter molecules to analyze metabolic activity in cells
US5352803A (en) * 1992-03-30 1994-10-04 Abbott Laboratories 5(6)-methyl substituted fluorescein derivatives
JPH08505121A (ja) 1992-09-03 1996-06-04 アプライド バイオシステムズ，インコーポレイテッド 分子プローブとしての４，７−ジクロロフルオレセイン染料
US5525088A (en) * 1994-11-14 1996-06-11 Mayne; Louise L. Soft sculpture toy apparatus
US5798276A (en) * 1995-06-07 1998-08-25 Molecular Probes, Inc. Reactive derivatives of sulforhodamine 101 with enhanced hydrolytic stability
US6162931A (en) * 1996-04-12 2000-12-19 Molecular Probes, Inc. Fluorinated xanthene derivatives
US5847162A (en) * 1996-06-27 1998-12-08 The Perkin Elmer Corporation 4, 7-Dichlororhodamine dyes
US6017712A (en) * 1996-06-27 2000-01-25 Lee; Linda 4,7-dichlororhodamine dyes
US6080852A (en) * 1996-06-27 2000-06-27 The Perkin-Elmer Corporation 4,7-dichlororhodamine dyes
US5846737A (en) * 1996-07-26 1998-12-08 Molecular Probes, Inc. Conjugates of sulforhodamine fluorophores with enhanced fluorescence
US5696157A (en) * 1996-11-15 1997-12-09 Molecular Probes, Inc. Sulfonated derivatives of 7-aminocoumarin
US5830912A (en) * 1996-11-15 1998-11-03 Molecular Probes, Inc. Derivatives of 6,8-difluoro-7-hydroxycoumarin
US6348599B1 (en) * 1997-07-28 2002-02-19 Nycomed Amersham Plc Cyanine dyes
US6130101A (en) * 1997-09-23 2000-10-10 Molecular Probes, Inc. Sulfonated xanthene derivatives
US6008379A (en) * 1997-10-01 1999-12-28 The Perkin-Elmer Corporation Aromatic-substituted xanthene dyes
US5936087A (en) * 1997-11-25 1999-08-10 The Perkin-Elmer Corporation Dibenzorhodamine dyes
DE19824535A1 (de) * 1998-06-03 1999-12-09 Roche Diagnostics Gmbh Neue Rhodamin-Derivate und deren Verwendung
JP3983404B2 (ja) * 1999-01-13 2007-09-26 本田技研工業株式会社 レーダ搭載車両用ゲート
US6664047B1 (en) * 1999-04-30 2003-12-16 Molecular Probes, Inc. Aza-benzazolium containing cyanine dyes
US6403807B1 (en) * 1999-07-06 2002-06-11 Surromed, Inc. Bridged fluorescent dyes, their preparation and their use in assays
US6358684B1 (en) * 1999-08-27 2002-03-19 Pe Corporation UV excitable fluorescent energy transfer dyes
US6459276B1 (en) * 2000-08-02 2002-10-01 American Standard Inc. Rotor analyzer for an induction motor
US6716979B2 (en) * 2000-08-04 2004-04-06 Molecular Probes, Inc. Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
US7169922B2 (en) * 2000-08-04 2007-01-30 Invitrogen Corporation Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
WO2002026891A1 (en) * 2000-09-29 2002-04-04 Molecular Probes, Inc. Modified carbocyanine dyes and their conjugates

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525088B1 (en) * 1998-03-31 2003-02-25 Tetsuo Nagano Agent for measurement of singlet oxygen

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133136B2 (en) 2004-06-01 2015-09-15 University Of Virginia Patent Foundation Dual small molecule inhibitors of cancer and angiogenesis
US8298512B2 (en) * 2004-06-01 2012-10-30 University Of Virginia Patent Foundation Methods of determining β-III tubulin expression
US8642610B2 (en) 2004-06-01 2014-02-04 University Of Virginia Patent Foundation Dual small molecule inhibitors of cancer and angiogenesis
US8178545B2 (en) 2004-06-01 2012-05-15 University Of Virginia Patent Foundation Dual small molecule inhibitors of cancer and angiogenesis
US20070134161A1 (en) * 2004-06-01 2007-06-14 Brown Milton L Methods of determining beta-iii tubulin expression
US7842823B2 (en) 2005-10-27 2010-11-30 The Regents Of The University Of California Fluorogenic probes for reactive oxygen species
WO2007050810A3 (en) * 2005-10-27 2009-04-30 Univ California Fluorogenic probes for reactive oxygen species
US20070141658A1 (en) * 2005-10-27 2007-06-21 The Regents Of The University Of California Fluorogenic probes for reactive oxygen species
US20110015529A1 (en) * 2006-03-31 2011-01-20 Mauna Kea Technologies Methylene blue based fibred fluorescence microscopy
US20100019169A1 (en) * 2007-01-29 2010-01-28 Michigan Molecular Institute Remote laser interrogation of threat clouds and surfaces
WO2008118254A3 (en) * 2007-01-29 2008-11-27 Michigan Molecular Inst Remote laser interrogation of threat clouds and surfaces
WO2008118254A2 (en) * 2007-01-29 2008-10-02 Michigan Molecular Institute Remote laser interrogation of threat clouds and surfaces
WO2009048525A3 (en) * 2007-10-05 2009-05-28 Hercules Inc Selectivity improvement in oxygen delignification and bleaching of lignocellulose pulp using singlet oxygen
WO2009048525A2 (en) * 2007-10-05 2009-04-16 Hercules Incorporated Selectivity improvement in oxygen delignification and bleaching of lignocellulose pulp using singlet oxygen
WO2009121247A1 (en) 2008-04-05 2009-10-08 Versitech Limited Luminescence quenchers and fluorogenic probes for detection of reactive species
EP2250177A1 (en) * 2008-04-05 2010-11-17 Versitech Limited Luminescence quenchers and fluorogenic probes for detection of reactive species
EP2250177A4 (en) * 2008-04-05 2011-05-11 Versitech Ltd LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR THE DETECTION OF REACTIVE SPECIES
US8791258B2 (en) 2008-06-10 2014-07-29 The Regents Of The University Of California Pro-fluorescent probes
US20110130306A1 (en) * 2008-06-10 2011-06-02 The Regents Of The University Of California Pro-fluorescent probes
WO2009152102A3 (en) * 2008-06-10 2010-04-22 The Regents Of The University Of California Pro-fluorescent probes
WO2009152102A2 (en) * 2008-06-10 2009-12-17 The Regents Of The University Of California Pro-fluorescent probes
CN102344464B (zh) * 2011-07-20 2014-03-26 北京师范大学 高水溶性钌金属配合物单线态氧荧光探针及其制备和应用
CN102344464A (zh) * 2011-07-20 2012-02-08 北京师范大学 高水溶性钌金属配合物单线态氧荧光探针及其制备和应用
US20130171027A1 (en) * 2011-12-29 2013-07-04 Honeywell International Inc. Oxygen sensors based on hard-soft acid-base relationships
CN103554126A (zh) * 2013-11-15 2014-02-05 西安石油大学 油田用示踪剂的荧光素衍生物制备方法与应用
CN103554126B (zh) * 2013-11-15 2016-04-13 西安石油大学 油田用示踪剂的荧光素衍生物制备方法与应用
CN103755672A (zh) * 2014-01-26 2014-04-30 大连理工常熟研究院有限公司 一种用于识别半胱氨酸的特异性荧光探针及其应用
CN103755672B (zh) * 2014-01-26 2016-08-17 大连理工常熟研究院有限公司 一种用于识别半胱氨酸的特异性荧光探针及其应用
US10809242B2 (en) * 2014-05-19 2020-10-20 Technion Research & Development Foundation Limited Method for detection of an analyte/explosive on a sample surface
US11906498B2 (en) 2014-05-19 2024-02-20 Technion Research & Development Foundation Ltd. Swab composition for detection of molecules/explosives on a surface
CN105334170A (zh) * 2015-06-11 2016-02-17 北京市环境保护监测中心 大气颗粒物表面有机活性物质的检测方法
CN109251206B (zh) * 2018-09-21 2022-02-08 上海大学 水溶性铂-卟啉配合物及其制备方法
CN109251206A (zh) * 2018-09-21 2019-01-22 上海大学 水溶性铂-卟啉配合物及其制备方法
CN110003355A (zh) * 2019-04-12 2019-07-12 安徽大学 一种具有aie特征的葡聚糖衍生物及其合成方法和用途
CN113999247A (zh) * 2021-11-03 2022-02-01 安徽理工大学 一种荧光酮类试剂的制备方法

Also Published As

Publication number Publication date
US20080160627A1 (en) 2008-07-03
US8173698B2 (en) 2012-05-08

Similar Documents

Publication Publication Date Title
US8173698B2 (en) Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection
US9846168B2 (en) Fluorescent metal ion indicators with large stokes shifts
US9644099B2 (en) Violet laser excitable dyes and their method of use
US9212385B2 (en) Fluorinated resorufin compounds and their application
US8680320B2 (en) Heavy metal binding compounds and their method of use
US20090181364A1 (en) Zinc binding compounds and their method of use
US8614294B2 (en) Pyrenyloxysulfonic acid fluorescent agents
US8604243B2 (en) Fluorescent ion indicators for cadmium and lanthanide ion detection
US8445702B2 (en) Zinc binding compounds and their method of use
US20050250957A1 (en) Compounds containing thiosulfate moieties

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION